Lawsuit Category Browser

Hysterectomy Side Effects

2012-05-15T20:58:03+00:00

Hysterectomy Side Effects

Hysterectomy, or the surgical procedure to remove the uterus, accounts for the maximum number of gynecological surgery cases in the United States. The surgical approach is widely used to treat uterine, ovarian, and cervical cancers and other medical conditions related to the uterus, such as chronic pelvic pain, non-cancerous tumors in uterus, endometriosis, prolapsed and thickening of the uterus, and abnormal vaginal bleeding. Though the surgical approach is found highly effective in curing serious gynecological conditions of women, it results in a number of side effects and is found to diminish long-term survival rates of patients.

Hysterectomy Statistics

Hysterectomy ranks second in the number of overall surgeries performed on reproductive women in the United States, according to the National Women’s Health Information Center, a part of the Centers for Disease Control and Prevention. With an average of 622,000 women undergoing surgical removal of uterus every year, hysterectomy accounts for the highest number of non-obstetrical surgeries performed on women in the country. The American Journal of Obstetrics and Gynecology claims that about 75 percent of hysterectomies performed in the country violate guidelines of the American College of Obstetricians & Gynecologists.

According to a 2007 report by the National Center for Health Statistics,

Prescription Drugs Addiction During Pregnancy And Opiate Abuse

2012-05-03T08:53:43+00:00

Prescription Drugs Addiction During Pregnancy And Opiate Abuse

Opiate Painkiller Abuse Number of Newborns With Withdrawal Syndrome Triples

A study published in the Journal of the American Medical Association on April 30, 2012 claims that the number of newborns with neonatal abstinence syndrome, a postnatal withdrawal condition caused by maternal drug abuse, has increased threefold over the past decade. According to the research report, about 13,500 babies born in the United States in 2009 – roughly one baby per hour – experienced withdrawal syndrome because of their exposure to opiates while in the womb. A part of the larger national research on painkiller abuse, the study highlights that there has been a five-time increase in the consumption of opiate painkiller drugs, such as Oxycontin and Vicodin, by pregnant women between 2002 and 2009.

Opiate drugs, such as Oxycontin, Vicodin, Dilaudid, and others containing codeine, morphine, heroin, methadone, oxycodone, and hydrocodone, are allowed for the treatment of pain arising out of injuries or surgeries. However, the recent analysis by medical scholars and healthcare professionals gives startling revelations about the widespread abuse of the prescription opiate and its impact on public health. Almost 85 percent of the withdrawal syndrome cases in newborns are attributed to opiate abuse by expectant mothers. In 2009, the latest study year, researchers discovered traces of drugs in the bodies of 5/6 1,000 women.

The discharge records for newborns collected from 4,000 hospitals across the United States highlighted that

Victoza Side Effects Lawsuit Information

2012-04-26T12:16:51+00:00

Victoza Side Effects Lawsuit Information

Victoza Side Effects

Consumer advocacy group Public Citizen has called for a ban on the sale of popular diabetes drug Victoza, claiming that side effects of the injectable medication outweigh its benefits. A petition filed with the FDA by the group on April 19, 2012 has cited enhanced risk of pancreatitis, thyroid cancer, renal failure, and severe allergic reactions as Victoza side effects, which pose serious health concerns for diabetics. The consumer advocacy group also referred to the objections made by two pharmacologists and one clinical safety reviewers against the drug prior to its approval.

Public Citizen Health Research Group director Dr. Sidney Wolfe has criticized the FDA for allowing marketing of the drug despite serious safety issues mentioned on the drug label. The consumer group has also presented documented facts, showing threefold increase in the risk of thyroid cancer and pancreatitis. According to the group, about 2,000 diabetes patients experienced painful Victoza side effects, including 200 cases of pancreatitis, within the first 17 months since the introduction of the drug in the market. The group advocates removal of the drug from the market, saying that the FDA label warnings have proved insufficient.

Breast Cancer Treatment Side Effects Lawsuit

2012-04-25T02:10:28+00:00

Breast Cancer Treatment Side Effects Lawsuit

Breast Cancer Treatment Side Effects

According to a new study conducted by researchers at the Perelman School of Medicine, Pennsylvania University, over 60 percent breast cancer survivors experience treatment-related complications six years after diagnosis. The study published in a special issue of Cancer, mouthpiece of the American Cancer Society, says that side effects of drugs and breast cancer treatment complications linger on for years despite successful treatment. About 2.6 million breast cancer survivors continue to suffer due to these side effects.

Research Studies on Side Effects of Breast Cancer Treatments

One in every eight U.S. women is a victim of breast cancer during their lifetime. In 2011, more than 230,000 women were diagnosed with the disease, and the figures are expected to rise in the coming years, according to the American Cancer Society. Breast cancer patients must undergo surgery along with other therapies, including radiation treatment, chemotherapy, hormone blocking therapy, and monoclonal antibody therapy, to get rid of the condition. However, these therapies do have some serious side effects.

In April 2012, a group of scholars at the University of Pennsylvania highlighted a number of physical and functional complications that breast cancer survivors have to undergo following surgery, chemotherapy, radiotherapy, and hormonal treatment. According to the study based on 287 Australians, who successfully overcame breast cancer after treatment, almost 60 percent of the survivors experienced postsurgical complications, upper body dysfunction, weight gain, leg swelling caused by lymphedema, fatigue, and

Victoza Side Effects Lawsuit

2012-04-24T09:37:35+00:00

Victoza Side Effects Lawsuit

Public Citizen & doihavealawsuit.com reccomends the FDA halt sales of Novo Nordisk drug Victoza due to side effects.

An active petition to the FDA states that the diabetes drug Victoza made by Novo Nordisk endangers patients by putting them at a higher risk of thyroid cancer, kidney failure and pancreatitis, as a result of Victoza side effects. We do not believe that these side effects associated with Victoza are worth the benefits gained by patients taking the drug.

Victoza was approved by the FDA in 2010 regardless of the fact that two pharmacologists at the agency advised against pharmaceutical sales of Victoza. The FDA had also previously issued new warnings linking the drug to serious safety risks, including renal failure.

"The agency simply describes the risks in the drug label and hopes that physicians and patients will pay attention," Dr. Sidney Wolfe, director of Public Citizen’s Health Research Group. "Clearly, the FDA’s warning system is not sufficient. The drug should be taken off the market."

Cruise Ship Lawsuit

2012-04-09T20:25:45+00:00

Cruise Ship Lawsuit

Cruise Ship Liability and Admiralty Lawsuit

On March 31, 2012, US marshals briefly seized the MS Carnival Triumph owned by Miami-based Carnival group after a Texas federal judge issued arrest warrants following filing of a cruise ship liability lawsuit seeking 10 million in damages from the world’s biggest cruise operator. The lawsuit filed in a Galveston-based court on behalf of a deceased German woman is one of the many lawsuit filed against the luxury cruise liner operator following the Costa Concordia disaster off the Italian coast. Judge John Froeschner found ample reason to order attachment of joint and collective property held by the defendant within the district under the laws governing admiralty and maritime claim in the United States.

Cruise ships departing from any of the ports in the United States are legally viewed as common carriers of passengers. The ships designated passenger carriers have the duty to ensure safety and wellbeing of passengers until they reach their destinations. Tourists spend thousands of dollars to enjoy exotic cruise vacation with the expectation that they enjoy their holidays on board safely and without any inconvenience. However, mismanagement by the cruise operator, negligence of safety issues, and failure to maintain proper standards often contribute to falls, injury, loss of life, fire, food poisoning, and lack of medical facilities on the ship. Most of these accidents are preventable and occur only because of sheer negligence of the cruise staff. Passengers are entitled to file cruise ship liability lawsuits evoking various provisions of the Admiralty Law.

Surgical Error Malpractice Lawsuit

2012-04-02T18:43:11+00:00

Surgical Error Malpractice Lawsuit

Surgical Error Lawsuit

On February 17, 2012, a surgical error lawsuit filed in a Chicago court resulted in $7.5 million award to the family of an Illinois man, who died following a robotic surgery on his spleen. A month prior to the judgment, a Clark County jury awarded $1.5 million to a 30-year-old woman who suffered from a permanent debilitating condition because of late surgery. About 12,000 patients die and millions others face medical conditions caused by surgical errors in the United States every year due to wrong surgery, surgical lapses leading to infection or removal of body parts, surgical error resulting in injury and death, delay in surgery, incorrect procedure, post-surgery medication errors, and surgical instruments left in the body during the procedure. According to a report by the Office of Inspector General, Department of Health and Human Services, more than 80% of surgical error cases go unreported.

Surgical errors fall under medical malpractice, and victims have every right to seek justice. They are entitled to file surgical error lawsuits claiming damages for injuries caused due to surgical mistakes or failure of doctors or hospital staff to take complete medical care of patients they are operating on.

Surgical Error: Meaning and Types

Most of the surgical error lawsuits claim damages citing negligence by doctors during the operation, inadequate care by hospital staff, and wrong surgical procedure. A surgical error is a medical mistake caused on the operating table, leading to injuries to a patient that could have been prevented. The court judgments in various surgical error lawsuits have expanded the definition of surgery mistakes to include injuries caused due to medical negligence prior to and after an operation. One can sue a surgeon or hospital for,

pre-operative surgical errors caused by failure to properly diagnose a medical condition requiring surgery and suggest the most effective procedure to be adopted. There are instances where wrong diagnosis or faulty pathology report resulted in unnecessary surgery of patients. Doctors preferring surgery to medication are also liable to be sued for wrong suggestion.
surgical errors during the operation caused due to wrong surgical procedure, inexperienced doctors and staff, lack of attention, wrong organ removal, incorrect incisions, wrong site surgery, anesthesia error, use of faulty or unsterilized equipment, or instruments left inside the patient’s body.
post-operative surgical injuries caused due to inadequate care by hospital, wrong medication, preventable infections, or inexperienced doctors, or improper handling of surgery requiring a patient to undergo surgery again.

Grounds for Filing Surgical Error Lawsuit

A patient undergoes a lot of physical and financial strain before and after a surgery. They suffer from further injuries and medical complications if the surgery goes wrong because of mistakes on the part of doctors or the hospital. The law of the land allows them or their family to file a surgical error lawsuit seeking punitive damages for those responsible for professional negligence and medical malpractice that resulted in the injury.

Zocor Side Effects Lawsuit

2012-03-24T10:48:26+00:00

Zocor Side Effects Lawsuit

On February 28, 2012, the Food and Drug Administration issued a public health warning informing patients that cholesterol lowering drugs, including Merck’s Zocor, could lead to enhanced risk of diabetes, muscle injury, high blood pressure, and cognitive disorders, such as loss of memory and mental confusion. This was followed by another FDA warning on March 2nd that the drug used along with HIV and Hepatitis C medication could result in kidney failure and death. The federal health regulator has also sought additional drug label changes for Zocor, citing an increased risk of myopathy and rhabdomyolysis.

Merck is facing an increasing number of product liability lawsuits from people that had been using Zocor to lower their cholesterol and have suffered from life-threatening conditions. In fact, a number of studies claim that the cholesterol-lowering statins pose an increased risk of muscle injury, liver damage, rhabdomyolysis, and other life-threatening problems. The FDA has warned that 80 milligram dose of Zocor poses a high risk of severe muscle damage and disintegration of muscle tissues, which can lead to kidney failure.

Pradaxa Side Effects Bleeding Lawsuit

2012-03-21T16:39:21+00:00

Pradaxa Bleeding Lawsuit

Pradaxa Internal Bleeding

On March 1, 2012, a report published by the New England Journal of Medicine claimed that hemorrhage and other serious consequences of using Pradaxa and similar blood thinners was because of the absence of an effective reversal agent to stop bleeding caused by these drugs. According to a meta-analysis published by the Institute for Safe Medication Practices in January 2012, there was a considerable increase in the number of Pradaxa internal bleeding incidents in the first quarter of 2011. The FDA has received more than 500 Pradaxa hemorrhage complaints through its Adverse Event Reporting System, which is significantly higher than the number of such hemorrhages involving other blood thinners, such as Coumadin and drugs containing warfarin.

Zoloft Side Effects Lawsuit Birth Defects

2012-03-07T11:04:20+00:00

Zoloft Birth Defects Lawsuit

A group of mothers led by a St. Louis woman have filed a class action lawsuit in February 2012, blaming birth defects of their children on Pfizer’s antidepressant Zoloft. The plaintiffs have accused Pfizer of misleading consumers about congenital birth defects associated with its

antidepressant drug Zoloft and claimed that the drug manufacturer failed to adequately test the drug for its side effects. The Zoloft class action came within a fortnight of filing of another similar lawsuit filed by two Louisiana couples alleging that Pfizer concealed information disclosing the link between the antidepressant drug and possible birth defects for commercial gains.

In 1991, Pfizer introduced Zoloft (sertraline), belonging to the class of selective serotonin reuptake inhibitors, SSRIs, as a treatment for obsessive-compulsive disorder, depression, and anxiety. By 2007, the drug became widely popular as an antidepressant in the United States. However, in the recent years, numerous adverse event reports have surfaced, suggesting that use of Zoloft during pregnancy poses an increased risk of potentially life-threatening health problems for newly born babies. Further, a growing amount of research suggests that use of the antidepressant during pregnancy causes persistent pulmonary hypertension in newborns, cranial defects, lung defects, spina bifida, abdominal defects, heart defects, and other malformations.

Cooper Vision Avaira Toric Contact Lens Lawsuit

2012-03-06T00:38:07+00:00

Cooper Vision Avaira Toric Contact Lens Lawsuit

A class-action lawsuit filed by CooperVision shareholders in December 2011 has accused the eye healthcare manufacturer of hiding information about the low quality of its products and presence of silicone oil residues in Avaria Toric and Sphere contact lenses until the FDA called for their market withdrawal. In 2011, CooperVision recalled 6.6 million Avaria Toric and Sphere Contact Lenses, meant for the treatment of nearsightedness and farsightedness in patients suffering from astigmatism. According to the FDA and independent research reports, Avaria contact lenses could lead to potentially serious eye complications, including distorted vision, torn corneas, and even loss of vision.

Cooper Vision Recalls Avaria Contact Lenses

In August 2011, CooperVision issued a voluntary recall of its Avaria Toric contact lenses after receiving complaints from patients about the serious side effects of using the product. On August 19, 2011, CooperVision issued a limited recall to some healthcare professionals and distributors in the United States. A week later, it issued a notice to foreign distributors about the recall of the contact lenses over some “unidentified residue” that had spilled on the lenses; however, the manufacturer failed to send any public notification about the dangers of using the product. It posted a press release about the limited recall on its website, but did not distribute it publicly, thus failing to inform the public at large about the recall and possible side effects of the product. The manufacturer did not bother to adequately notify consumers that the silicone residue was creating problems and that they might have already been exposed to it.

On November 15, 2011, CooperVision issued a massive recall of both Avaira Sphere and Toric Contact Lenses under pressure from the FDA. The company expanded the earlier recall to include more than six million Sphere contact lenses after having identified that certain lots did not meet the updated quality standards due to the unintended presence of silicone oil residue. The recall affects contact lenses manufactured between November 2010 and August 2011. Before the November recall, the FDA estimated that about 778,301 of the distributed contact lenses were thought to have been affected by the recall.

Medtronic Infuse Bone Graft Lawsuit

2012-03-03T22:54:08+00:00

Medtronic Infuse Bone Graft Lawsuit

Medtronic Infuse Bone Graft: Complications, Side Effects, Lawsuit

Medtronic’s Infuse Bone Graft puts patients implanted with it at a higher risk of breast, pancreatic, and prostate cancers, according to a research report presented at the North American Spine Society in October 2011. The study has expressed concern over the link between potential risk of cancer and rhBMP-2 bioengineered bone growth protein present in the product. Researchers have discovered that patients implanted with Medtronic’s Infuse Bone Graft are 2.5 times more vulnerable to developing cancer within a year compared to patients without it.

Medtronic Inc., the largest medical technology supplier in the world, faces a number of personal injury and wrongful death Lawsuit over the off-label marketing of its Infuse Bone Graft, which has caused complications and life threatening injuries for many patients. The FDA has issued safety warnings over the unauthorized use of the infuse bone stimulator in the neck, linking it to serious complications in some patients.

The US Department of Justice has been carrying out a criminal investigation into the unauthorized marketing of Infuse and payments made by Medtronic to surgeons for recommending the off-label use of the product. According to a Wall Street Journal report, Medtronic is also accused of having paid a surgeon about $800,000 for fabricating results of a study conducted on the complications resulting from Infuse Bone Graft implants.

Merck Lawsuit Settlement

2012-03-01T10:32:10+00:00

Merck Lawsuit Settlement

International drug maker Merck & Co. has settled a shareholder lawsuit over the release of a potentially damaging study on the drug Vytorin.

At the center of this particular 4 year old lawsuit is shareholders claim that Merck & Co. delayed releasing the results of a study that Merck & Co had hoped would boost sells of it’s high cholesterol drug Vytorin. The study instead revealed data that would likely slow future sells of Vytorin.

The Vytorin ENHANCE study results revealed that Vytorin was equally effective at reducing plaque buildup as its one of its drug components in stand alone form. The study showed Zocor, one of the two components in Vytorin was just as effective when used alone as it is as a sub-component of Vytorin.

Vytorin has been a multi billion dollar seller for Merck and this is possibly the reasoning behind withholding of study data from patients and the public in general.

Wrongful Birth Lawsuit

2012-02-27T09:45:20+00:00

Wrongful Birth Lawsuit

In a complex case, the parents of a child born with cystic fibrosis has filed a lawsuit seeking damages as a result of health care providers failure to provide the most basic care in the form of prenatal testing that would have alerted the couple to the fact that their child would be born with the fatal disease.

The parents in this case are seeking damages for the mental and emotional distress caused by those health care providers when they failed to test , diagnose and inform the couple of their child's cystic fibrosis diagnosis. They will undoubtedly face additional healthcare ciosts in caring for the terminaly ill child and seek justice in the courts as a means to help pay for these expenses.

Montana health care providers have moved to have this case dismissed on the grounds of lack of precedent in situations of wrongful birth , and have stated that this lawsuit raises both moral and political questions that should probably be addressed by state and federal laws before any form of lawsuit can proceed.

Defendants named in the lawsuit include nurse Peggy Scanson , Livingston Healthcare , Bozeman OB/GYN , Dr. William Peters, Bozeman Deaconess Health Services and Shodair Children’s Hospital Department of Medical Genetics. Damages from this lawsuit will be determined by a jury.

The couple stated that they were provided with a report indicating that the baby was healthy.

Wright Medical Hip Lawsuit Implant Replacement

2012-02-27T09:16:05+00:00

Wright Medical Hip Lawsuit Implant Replacement

Wright Medical Hip Lawsuit

NEWS RELEASE

FOR IMMEDIATE RELEASE

LAWSUIT CITES DESIGN DEFECT, NEGLIGENCE IN FAILURE OF HIP-REPLACEMENT SYSTEM THAT FRACTURED IN PHOENIX PATIENT

Wright Medical Technology Changed Material in 2009, But Issued No Warnings or Recalls

PHOENIX, Ariz. (Feb. 22, 2012): A Phoenix man filed a lawsuit today in U.S. District Court against Wright Medical Technology, Inc. and Wright Medical Group, Inc. after needing emergency surgery following a sudden catastrophic fracture of the titanium modular neck of the Wright ProFemur Total Hip System as he was dressing for work last July.

Phoenix attorney Stephen Leshner and nationwide defective hip lawyer Joseph H. Saunders of Saunders & Walker P.A . filed the complaint against the Tennessee based company on behalf of Dale Purcell, who had the device implanted in June 2005 during a total left-hip replacement.

The Wright Medical ProFemur Total Hip System is comprised of three separate components which are assembled during surgery: a femoral head, a modular neck and the femoral stem.

Cigarette Tobacco Lawsuit

2012-02-27T09:10:56+00:00

Cigarette Tobacco Lawsuit

On January 26th, a Washington district court rejected the plea by tobacco majors, including Marlboro maker Philip Morris USA, to delay its verdict on placing graphic warning labels on cigarette packets. The 12-year-old lawsuit accuses the biggest US cigarette manufacturers of having concealed the risks associated with smoking for decades.

Judge Gladys Kessler has already ruled that the tobacco industry must pay for print and electronic ads informing people about the dangers of smoking cigarettes. However, her verdict regarding subject, design, placement, and duration of graphic warning labels on cigarette packets has yet to come. Executives and attorneys for big tobacco companies had requested that the court delay the judgment in view of pending litigation's over corrective label statements and marketing restrictions proposed by the United States government under federal tobacco regulations.

The Justice Department opposed the plea on grounds of postponing the verdict would result in failure to inform potential smokers and the youth about the risks of smoking. Regardless of the large number of Tobacco lawsuits filed after short and long term smokers developed lung cancer and many have died as a result of the link between cigarette smoking and lung cancer.

The Family Smoking Prevention and Tobacco Control Act gives the Food and Drug Administration the authority to impose warnings and label changes on packaging of tobacco products and restrict advertisements with the objective to discourage their uses and inform users of health hazards caused by smoking.

While the FDA wants cigarette packaging to carry images showing smoking pitfalls, the Justice Department wants the tobacco companies to fund corrective print and electronic advertisement campaigns. These ads showcasing nicotine addictiveness, dangers posed by passive smoking, and potential health hazards of "low tar," "ultra-light" and "mild" cigarettes are planned as self-criticism of tobacco companies for misleading people about health risks associated with their products. In another jolt to cigarette manufacturers, the first tobacco lawsuit of 2012 resulted in a court verdict, asking RJ Reynolds and Philip Morris to pay $2.5 million to the wife of a smoker who died as a result of

Transvaginal Mesh Lawsuit

2012-01-30T14:27:46+00:00

Transvaginal Mesh Lawsuit

Mesh Lawsuit Attorney

The Federal Drug Administration has issued a warning against the use of vaginal mesh implants and asked manufacturers, Johnson & Johnson and C.R. Bard Inc., to research rates of complications and organ damage linked to vaginal mesh implants. The transvaginal mesh has been the basis of multiple vaginal mesh lawsuits by attorneys nationwide.

The federal health regulator has received more than 3,000 reports of vaginal mesh implant complications and trans vaginal mesh side effects that have said to have injured many women in the United States. The manufacturers of these devices must be held liable for manufacturing and marketing defective products that have caused immense pain and suffering along with other complications among a large number of women users.

More than 650 lawsuits have been filed against vaginal mesh manufacturers of these defective devices, seeking compensation for the pain and suffering of the victims, lost wages, medical expenses and urging recall of the mesh implants, which had been cleared by the FDA for sale without human testing.

Vaginal Mesh Implant Attorney Studies

Further, a new study recently published in the Obstetrics and Gynecology journal has reported that women with mesh implants are more at a risk of requiring corrective surgeries within one year of the initial treatment than those treated for pelvic organ prolapse with other methods. The research found mesh erosion in one in six women merely three months after the device had been implanted surgically. Such women, the study says, face a higher rate of re-operation. Moreover, the study fails to find any improvement in the cure rates between the group treated with mesh implants and the no-mesh groups. The study questions whether the risks linked to mesh implants outweigh their benefits. Mesh lawsuit attorneys working with Do I Have A Lawsuit have in the past tried to answer this question for clients and the famalies of those who have been affected by the mesh implant.

Medical Malpractice Lawsuit

2012-01-30T14:25:46+00:00

Actos Bladder Cancer Lawyer

2012-01-23T15:22:59+00:00

Actos Bladder Cancer Lawyer

Actos Bladder Cancer Side Effects

Bladder cancer risk in patients using diabetes drug Actos dominated drug injury headlines in the United States and Europe for the last half of 2011. The top-selling diabetes drug with 60 percent of market share and $4.8 billion earning in 2010 was the number one choice of diabetics since 2007 following detection of cardiovascular risks linked to GlaxoSmithKline’s Avandia and consequent side effect lawsuits. Takeda Pharmaceuticals, the manufacturer of Actos, continues to claim that the drug helps reduce progression to Type 2 diabetes by 72%.

The recent discovery of Actos bladder cancer side effects risk, however, has raised safety concerns associated with the drug, and patients using the drug have flooded US courts, to file Actos related bladder cancer lawsuits. A report in Bloomberg has estimated that the total number of Actos side effect lawsuits could reach 10,000. On December 30, 2011, the Federal Judicial Panel on Multi District Litigation selected the Louisiana Western District federal court in Lafayette for consolidation of all Actos bladder cancer lawsuits.

Actos Bladder Cancer Side Effects Complaints

Actos is a class of drug known as thiazolidinediones and known as pioglitazone. Attorneys working with doihavealawsuit.com have stated that Actos can increase the risk of bladder cancer in diabetics using it for more than one year. The risk rises with the increase in duration and cumulative dose of the drug. Actos bladder cancer lawyers have indicated that this paticular risk was discovered by FDA as early as September 2010 when a safety assessment by manufacturer Takeda hinted at the possibility of such danger.

On June 9, 2011, the French Agency for the Safety of Health Products instructed Takeda to recall Actos following the discovery of comparatively higher bladder cancer risk in diabetes patients who took the drug. Next day, Germany’s Federal Institute for Drugs and Medical Devices suspended the sale of the Actos nationwide pending the conclusion of investigations into Actos bladder side effects and tumor dangers. On June 15th, the FDA warned consumers and doctors about the potential bladder cancer risk linked to Actos. It formally updated labels and added black box warning to the drug on August 5, 2011, informing patients about the risk.

Do i Have A Lawsuit Attorneys Investigate

Actos Bladder Cancer lawyer filed a class action lawsuit filed in Louisiana in September 2011 claims that manufacturer Takeda was aware of Actos bladder cancer side effects after a cancer study in 2005 resulted in the discovery of drug induced tumors in rats. However, the safety information was withheld by Takeda.

Actos Bladder Cancer Research Studies

US FDA Report on Actos Bladder Cancer Risk

The federal regulator added black box warnings to Actos for bladder cancer side effects in June 2011, though it stopped short of recalling the drug pending further investigation. The FDA came to know about the Actos bladder cancer risk in September 2010 after mid-term report of a study sponsored by Takeda pointed to such a possibility. The drug safety study planned over 10 years concluded that the use of Actos for more than 24 months puts diabetes patients at a statistically higher risk of bladder cancer. The FDA has been conducting a comprehensive safety review of the drug since then. Its order on label change is viewed as an endorsement of the findings linking Actos to enhanced bladder tumor risk.

In May 2011, a meta-analysis report also highlighted "disproportionate bladder cancer risk” in diabetics taking Actos for a long time. The survey based on half million complaints against different diabetes medications received by the FDA adverse event reporting system highlighted that one-fifth of diabetics with bladder cancer were using Actos.

European MedicalAgency Study on Actos Bladder Cancer Risk

The European Medical Agency has also found a relatively higher risk of bladder cancer in Actos users. It used a public health alert in July 2011 cautioning doctors against prescribing the drug to patients with potential bladder tumor risk following a four-month safety review of the drug. The report of the study carried by EMA’s Committee for Medicinal Products for Human Use between March and June 2011 called for mandatory monitoring of patients during the first three to six months of Actos use. It advised doctors to follow patient selection and exclusion process before prescribing the drug to reduce Actos bladder cancer risk. The EMA also called for a pan-European epidemiological study on the risk of the drug among different age groups.

France Report on Actos Bladder Cancer Risk

Actos bladder cancer risk came to limelight following the decision by French national drug regulator to disallow the marketing of the drug. A clinical study commissioned by the French National Health Insurance first publicly highlighted a close association between the drug and bladder tumor. It evaluated cancer risk in 155,000 diabetes patients prescribed Actos and other pioglitazone drugs between 2006 and 2009. A comparative analysis of the risk results with similar threat to 1.3 million diabetics using other drugs disclosed that Actos users were 22 percent more prone to bladder cancer than patients taking other medications. The report concluded that patients with cumulative pioglitazone dosage of 28,000 mg or above face significant cancer risk.

Medical Malpractice Lawsuit

2012-01-18T07:46:42+00:00

Medical Malpractice Lawsuit

In what can be called the height of medical malpractice and negligence, an eye surgeon first operated four-year-old Jesse on the wrong eye and then on the correct eye. Parents of the child, considering a medical malpractice lawsuit against the guilty doctor, accuse him of negligence and failure to properly inform them about the surgery and blame him for the unnecessary side effects on the vision of their boy.

The parents contend that their son as suffering from a wandering right eye and thus needed the operation. However, they claim that even after the surgery, no improvement has been noted; rather, the wrong surgery has left the left eye wandering. They allege that the negligent doctor informed them about the surgery on both eyes only after having operated the wrong eye.

On the other hand, the guilty doctor admits that she “lost sense of direction” and operated the wrong eye. She blamed her assistant for “accidentally” rubbing off the spot to mark the correct eye for the surgery.

Such a gross negligence and medical practice calls for punishment of the offender.

Medical Malpractice Statistics

This is not the only medical malpractice incident of its kind in the country. Unnecessary surgeries, hospital errors, doctor’s negligence, wrong diagnosis contribute to the rising medical malpractice statistics. In fact, it is the third leading cause of death in the United States. According to the Journal of American Medicine, more than 225,000 patients lose their lives annually from medical errors – 106,000 from prescription drug side effects, 80,000 from hospital infections, 12,000 from unneeded surgeries, and 7,000 from wrong diagnosis.

Further, cost of health care, lost wages due to medical malpractice stands at about $25 billion annually. Statistics reveal that more than 8,000 physicians and doctors commit malpractice errors annually and of every eight malpractice injuries, only one malpractice claim is made.

Let us have a look at some of the medical practice and negligence cases, some of which are awaiting justice, while some others have gone in favor of the plaintiffs.

Medical Malpractice Lawsuits Awarded in Favor of Plaintiffs

Recently, a plaintiff in a medical malpractice lawsuit has won a big award at the Erie County Courthouse. The lawsuit accused two physicians of medical malpractice in the case of Carolyn Champlin for failing to properly diagnose that she was suffering from lung cancer, which “went from operable and curable to inoperable and incurable," after which she died in April 2005. The jury found both doctors guilty of negligence and wrong diagnosis and returned a $1.8 million verdict in favor of the plaintiff.

In another medical malpractice case, the jury has recently awarded $21.6 million to the plaintiff, who claimed botched delivery of her son at Hamot hospital, resulting in brain damage and cerebral palsy to the child, as the hospital staff did not do enough to supply oxygen to the child at the time of delivery. While giving the verdict, which is the largest in the history of Erie County, the jury found the defendant hospital guilty of malpractice, which left the child profoundly disabled for life and permanently under the care of others. The verdict includes compensation for the past medical expenses and lost lifetime earning capacity, besides his future medical expenses.

In another similar case, a doctor who failed to properly diagnose colon cancer in a patient faces medical negligence lawsuit. The plaintiff alleges that the defendant did not conduct the required tests on him to diagnose his colon cancer, due to which he could not get timely treatment, causing him pain and suffering and decreased life expectancy. The jury awarded $2.5 million verdict in favor of the plaintiff.

A DuPage County jury awarded a medical negligence lawsuit an $11.5 million award. The plaintiff alleged medical negligence on the part of the Naperville's Edward Hospital staff at the time of her delivery, which caused death of her unborn child and loss of her small intestine. The plaintiff alleges that due to the negligence of the medical staff, she cannot become pregnant again. The jury found the hospital guilty of negligence and awarded the lawsuit to the plaintiff.

Rising Number of Medical Malpractice Lawsuits

Recently, a Chicago couple has filed a malpractice and negligence suit in the Cook County Circuit Court against a renowned hospital in Illinois, alleging that the hospital staff administered 60 times the prescribed dosage of sodium chloride to their 40-year-old infant, which caused his death. The plaintiffs seek unspecified damages against the Advocate Lutheran General Hospital for its staff’s negligence in conducting proper medical care of their infant, who was recovering well from a premature birth, which has caused them immense pain and incredible loss.

In another medical malpractice lawsuit filed against an Indiana doctor Mark Weinberger, the plaintiff alleges negligence and noncompliance with the standard of care on the part of the defendant in diagnosing that the victims was suffering from lung cancer. The lawsuit accuses the defendant of conducting an unnecessary sinus surgery on her, which resulted in serious complications for the victim and she died. The victim’s daughter who has sued the doctor seeks millions in punitive damages and compensation for the unneeded surgery, which cost her mother over $500,000 on medical bills and loss of projected lifetime earnings, besides the loss of her life.

In another such case, the jury sided with the plaintiff, a 20-year-old male, in deciding the outcome of the medical malpractice case against the Cook County Hospital. The plaintiff alleged that during the time of his birth, the hospital staff unnecessarily delayed the delivery, causing him permanent brain damage. The jury found the hospital guilty of negligence in giving timely care to the mother at the time of labor and delivery, which resulted in brain damage to the fetus.

In another medical negligence case against a Chicago-area hospital, a nurse midwife, and a sponsoring obstetrician, the plaintiff claimed that the child suffered brain injury at birth due to hypoxia, causing him cerebral palsy. The lawsuit alleged that the midwife did not perform intrauterine resuscitation immediately before the baby's birth even as the fetal heart rate was constantly dropping. The plaintiff contended that the back-up obstetrician could not properly perform the required procedure of providing oxygen and blood supply to the fetus, causing fetal distress. The lawsuit alleged that the hospital failed to provide a registered surgeon for the delivery of the baby. The case was settled before it went for trial, and the defendant hospital offered unspecified damages to the plaintiff for settling the case.

Discrimination Lawsuit

2012-01-07T00:30:49+00:00

Discrimination Lawsuit

A former gay employee of Harris County Hospital District has won a discrimination lawsuit in Judicial District Court of Harris County, Texas. In a 10-2 verdict, the jury has awarded $102,000 in back wages to R. Michael Lee, who was terminated after he complained of sexual harassment at the workplace. The complainant asserts that he has been unable to find a job since his termination.

The lawsuit claims that the plaintiff suffered from sexual discrimination at the hands of his colleagues at the workplace. The plaintiff alleges that his employer retaliated against him when he complained of discrimination against his colleagues and terminated him two weeks later. While awarding the case to the plaintiff, the Harris County jury found that the defendant retaliated against the plaintiff as a result of his complaint.

The plaintiff complains that while working as a senior project manager, he felt “personally attacked” when his seniors made a homophobic remark targeting him. The complainant alleges that when he made a formal complaint to his supervisors, the latter did not take any action. The lawsuit asserts that the supervisor, who was one of the persons accused of the incident, did not report the same to the hospital district. The plaintiff complains that, by doing so, the manager did not abide by the personnel policies of the hospital district and also discriminated against him.

Multaq Side Effects Lawsuit

2011-12-27T10:22:38+00:00

Multaq Side Effects Lawsuit

FDA Issues Black Box Warning for Multaq

On December 19th, the Food and Drug Administration has issued a new safety warning on antiarrhythmic drug Multaq restricting the recommended use of the heart-rhythm drug for patients with permanent atrial fibrillation. According to the results of the recent FDA trials, Multaq, generically known as dronedarone, has been found to increase the risk of serious cardiovascular events and even lead to death of patients with permanent atrial fibrillation. The drug already carries a warning that heart failure patients must avoid using Multaq.

The public safety alert was issued just after the completion of the FDA investigation of the Permanent Atrial Fibrillation Outcome Study Using Dronedarone on Top of Standard Therapy (PALLAS) clinical trial data. The PALLAS trial had to be terminated prematurely, as preliminary trials showed a significantly high number of serious cardiovascular events, systemic embolism, myocardial infarction, and even death in some patients on Multaq therapy.

The FDA black box warning for Multaq warns doctors

School Sexual Abuse Lawsuit

2011-12-20T16:58:58+00:00

Sexual Abuse Lawsuit

Lawsuit Claims Brooklyn's Poly Prep Covered Up Sexual Abuse by Iconic Football Coach Foglietta

Nine former students have accused Brooklyn’s elite Poly Prep Country School of covering up prolonged sexual abuse of dozens of players by Phil Foglietta, the once iconic football coach who served from 1966 to 1991. The sexual abuse lawsuit filed in 2009 claims that the school authorities started receiving complaints ever since Foglietta joined as coach, but did not act against him because of successful coaching and fund-raising accomplishments he had at Poly Prep during his four-decade tenure. A similar lawsuit filed against the school in 2004 was dismissed because of the statute of limitations. But the present lawsuit makes an attempt to invoke the Racketeer Influenced and Corrupt Organizations Act to bring a claim against the 157-year-old highly admired school.

The nine plaintiffs named in the sexual abuse lawsuit were sexually exploited by Foglietta more than once when they were members of Poly Prep football team between 1966 and 1981. David Hiltbrand, one of the victims, has disclosed to the media how he and a number of other students were sexually assaulted by Foglietta during the shower at the coaches’ locker room. Foglietta worked as both football coach and physical instructor at Poly Prep between 1966 and 1991. He died seven years later. According to the sexual abuse lawsuit, he sexually assaulted hundreds of students in cars, locker rooms, apartments, other places, and on squash courts, but the school authorities covered up complaints and even threatened to expel those who would report abuses.

David Harman, headmaster at Poly Prep, board of trustees, and a number of former present school officials have been named defendants in the sexual abuse lawsuit. The plaintiffs have sought $20 million for each victim in punitive damages and compensation.

Actos Bladder Cancer Side Effects Lawsuit

2011-12-12T19:26:02+00:00

Actos Bladder Cancer Side Effects Lawsuit

Actos Bladder Cancer Lawsuit

According to a report in Bloomberg, Takeda Pharmaceuticals may face more than 10,000 Actos side effect lawsuit over allegations linking the drug to bladder cancer and a host of adverse reactions in users. Actos has been the top-selling diabetes drug since 2007 after GlaxoSmithKline’s Avandia, another popular diabetes drug, lost ground following a spate of lawsuit linking it to cardiovascular and other fatal side effects. However, a mid-term FDA study report published in September 2010 disclosed that diabetes patients taking the drug face greater threat of suffering from bladder cancer.

In June 2011, the federal regulator warned about the risk of bladder cancer in patients using Actos for more than 12 months. The FDA has been monitoring the safety concerns related to the drug since last September. The disclosures prompted immediate withdrawal of the drug in France and Germany while a four-month study by the European Medical Agency also confirmed the potential cancer risk associated with Actos.

A large number of research reports have shown that Actos, known by its generic name pioglitazone, has a number of side effects that outweigh its benefits in the long run.

Actos Bladder Cancer

On June 15, 2011, a public health alert by the FDA highlighted a link between bladder cancer in diabetes patients and Actos side effects. It warned about higher risk of cancer in patients using the drug regularly for more than 12 months. The regulator was aware of Actos cancer side effects as early as September 2010 after the mid-term report of its 10-year long commissioned safety study came out. The FDA has warned healthcare professionals against prescribing Actos to patients with prior record of bladder cancer.

A study commissioned by the French National Health Insurance Fund has also found heightened bladder cancer risk in 155,000 diabetes patients in France treated with Actos from 2006 to 2009. According to the report, the Actos users with cumulative dosage exceeding 28,000 mg face

Sexual Abuse Lawsuit

2011-12-07T11:15:06+00:00

Sexual Abuse Lawsuit

Sexual Abuse Lawsuits

On November 11th, the Michigan Supreme Court upheld a sexual abuse lawsuit verdict by a lower court ordering the Department of Corrections to pay $100 million to 800 victims, who had alleged sexual abuse and harassment by the Oakland County prison staff in 1996. A day before, a Miami jury imposed $100-million fine on a former Roman Catholic priest in a child sexual abuse lawsuit and a young Indianapolis girl moved court against Indiana Swimming, USA Swimming, and Metropolitan School District of Lawrence Township, alleging sexual victimization by her coach. Earlier in the month, the entire nation was taken aback when a grand jury indicted Jerry Sandusky, an ex-football coach at Pennsylvania State University, for sexual abuse of eight young boys. The last two months have also witnessed filing of a number of sexual abuse lawsuits against Catholic priests, the Pentagon, universities, and sports bodies.

What is Sexual Abuse?

The law defines sexual abuse as

Penn State Sandusky Child Molestation Abuse

2011-11-07T19:20:32+00:00

Penn State Sandusky Child Molestation Abuse

An explosive sex abuse scandal and possible cover-up rocked "Happy Valley'' on Saturday when former Penn State defensive coordinator Jerry Sandusky, once considered Joe Paterno's heir apparent, was charged with sexually assaulting eight boys over a 15-year period. Among the allegations was a 2002 incident in which a graduate assistant for the team said he saw Sandusky assault a boy in the shower at the Nittany Lions' practice center.

Sandusky retired in 1999 but continued to use the school's facilities for his work with The Second Mile, a foundation he established to help at-risk kids. The state grand jury investigation also resulted in perjury charges against Tim Curley, Penn State's athletic director, and Gary Schultz, vice president for finance and business. The two administrators were accused of failing to alert police - as required by state law - of their investigation of the allegations.

“

Nursing Home Abuse Neglect Lawsuit

2011-11-04T22:32:48+00:00

Nursing Home Abuse Lawsuit

Nursing Home Neglect and Abuse Lawsuit

Nursing home neglect and abuse lawsuits have been on the rise following a $671 million class action award against California-based Skilled Healthcare in July 2010. Relatives of a 78-year-old Alzheimer’s patient have filed a nursing home abuse lawsuit against Pennsylvania-based Quadrangle Retirement Community and its parent organization Sunrise Senior Living for negligence, chronic understaffing, lack of trained workers, and violation of federal nursing home regulations. The lawsuit filed in the Delaware County court in the first week of October has sought unspecified damages accusing the nursing home staff of mocking, abusing, assaulting, forcing to go topless, and humiliating the residents and the management of failing to act despite complaints. A state investigation on their complaint led to arrest of three employees and temporary cancellation of license of the nursing home. The court is expected to make a decision on punitive damages, recovery, and compensation for medical malpractice to the victim and his family when the lawsuit goes on trial next month.

About 1.5 million American citizens live in 17,000 care homes across the country. According to a Congressional report, about one-third of them are reported every year for nursing home abuse lawsuits. A review of state inspection reports highlighted 9,000 abuses, including violence by staff members, and other violations by 5,283 nursing homes reported between 1999 and 2001. A CBS report in 2008 about Helen Love, who died days after being assaulted by an assistant at a Sacramento nursing home, created widespread protest in the country. The law empowers the residents, their family members, and relatives to file nursing home neglect lawsuits seeking damages for mistreatment, abuse, lack of facilities, injuries, illness, wrong medication, failure to diagnose, medical errors, disability, and death. Recovery of insurance and Medicare assistance are also covered under these nursing home abuse lawsuits.

Nursing Home Neglect and Abuse Grounds for Lawsuit

People turn to nursing homes to ensure that the residents get adequate care and the attention required to lead a happy and injury-free life. However, many of these centers

Head And Spinal Injuries Lawsuit

2011-11-03T17:00:57+00:00

Head And Spinal Injuries Lawsuit

On October 19th, Jose Ayela, a 50-year-old daily laborer, filed a spinal injury lawsuit in a New York court, seeking unspecified damages for head and spinal injuries he had sustained as a result of brutal assault by the owner and other employees of a paint store in New York.

The multiple spinal disk fractures have left the victim permanently disabled. On October 26th, the mother of a Massachusetts football player filed a brain injury lawsuit against Medford School District, holding it responsible for the brain injury suffered by her son. The North Medford High School player was sent back to play despite suffering a concussion earlier.

According to a study published by the Center for Disease Control and Prevention in 2010, about

50,000 U.S. citizens die and more than a million suffer from permanent disability every year due to

accidental brain and spinal injuries. The state and federal laws allow the victims and their families

to seek compensation through brain and spinal injury lawsuits to cover up their medical cost,

future earning loss, physical and emotional damages, rehabilitation, and other expenditures from

individuals or organizations responsible for causing injuries to them.

Grounds for Filing Brain and Spinal Injuries Lawsuit

A brain or spinal cord injury lawsuit covers almost all types of injuries to the brain and spinal cord

caused by

Auto Accident Lawsuit

2011-10-31T16:21:53+00:00

Auto Accident Lawsuit

Auto accidents are quite common on the roads of the United States. In fact, motor accidents are a common cause of property damage, injuries, and even death. In the country alone, more than 40,000 people die each year in motor accidents. Spinal cord injury and brain damage are the most common auto accident injuries.

Anybody involved in a car accident is entitled to receiving compensation for the injuries and damage to vehicle if the other party is at fault. In most cases, compensation involves payment of medical bills, lost wages, and other damages, including pain and suffering. Either the insurer or the guilty party is liable to pay the compensation, depending on the circumstances of the incident, degree or extent of injury, degree of fault of the responsible party, amount of damages, and the state’s laws on negligence.

One can file an auto accident lawsuit on a number of grounds. One can sue the culprit and seek punitive damages, medication cost, loss of earning, and other compensation when he becomes a victim of motorcycle accidents, bus accidents, bicycle accidents, hit-and-run accidents, pedestrian accident, and tractor trailer accidents and crashes. The definition of accident under auto lawsuits includes rear end collisions, rollover accidents, intersection accidents, crashes, alcohol and drug-related accidents, work-related motor accidents, and drunk-driving crashes.

Grounds for Filing Auto Accident Lawsuits

If you are a victim of auto accident, you can file lawsuits claiming damages on the following grounds.

Motorist Negligence: The driver is liable to compensate the victim for causing auto accidents or injury because of his negligence, distraction, or inattention.

Wrongful Death Lawsuit

2011-10-24T16:02:57+00:00

Wrongful Death Lawsuit

In legal jargon, wrongful death occurs when an individual dies due to the negligence or wrongful conduct of another. In other words, if an individual, organization, or group can be held liable for the death of another individual, it is a case for wrongful death. The suit for wrongful death may be brought by the decedent’s immediate family members, known as distributes, including spouses and children.

In the United States, each state has its own civil wrongful death statute, establishing procedures for bringing wrongful death suits. Such actions can be brought about for personal injury to the decedent, personal loss, pain and suffering, and expenses incurred prior to the death of the decedent. The damage awards belong to the decedent’s heirs and other beneficiaries.

Key Elements of Wrongful Death Lawsuit

The following elements are necessary to bring a successful wrongful death cause of action:
Death
Negligence of another individual or intent to cause harm leading to death
Monetary loss to heirs of the decedent as a result of death

A wrongful death claim is brought in a civil action, which is separate from criminal charges. Wrongful death statutes do not apply to a fetus, which has no distinct legal status until

Personal Injury Lawsuit

2011-10-18T21:17:19+00:00

Personal Injury Lawsuit

Personal Injury Lawyer

A personal injury lawsuit is a legal action that empowers one to seek compensation for damages, physical injuries, emotional distress, and loss of job caused by another. It addresses a civil wrong where negligence or deliberate malice on the part of one individual results in pain and suffering to another. According to the law, the victim has legal rights to sue the offender, who failed to ensure reasonable care, to recover losses caused by injury or harm to property.

Personal injury comes under the tort law designed to protect individuals from injuries or losses caused by willful act or negligence of another individual, organization, or even the state. The main purpose of the law is to send a strong message to the offender that they are liable for the harm caused to another and discourage them from committing the similar offense. A personal injury lawsuit entitles one to sue another individual or organization for pain and suffering, emotional distress, loss of earning capacity, companionship, and amenities, financial losses incurred, medical and legal expenses, and even expected future losses.

Grounds for Personal Injury Lawsuit

The spectrum of personal injury law is quite wide and includes a range of injuries and accidents, including

Duragesic Side Effect Lawsuit

2011-10-13T15:27:07+00:00

Duragesic Side Effect Lawsuit

Johnson & Johnson, Watson Pharmaceuticals, and Actavis are facing a large number of Duragesic lawsuits across the United States for life-threatening complications linked to the drug and wrong marketing practices. The FDA approved Duragesic skin patches in 2005 for the treatment of chronic and severe pain. These pain patches release fentanyl, a type of opioid medication, gradually through the skin and provide relief from pain for about 72 hours. However, Duragesic patches can cause life-threatening hypoventilation and withdrawal symptoms in patients who are not opioid tolerant. These skin patches also develop leakages when exposed to external heat sources and release too much fentanyl into the body, which can cause fatal health problems.

Duragesic FDA Warnings and Recalls

The FDA added black box warnings to Duragesic pain patches in 2005 following recommendations by its advisory panels. According to the warning on the label, these fentanyl skin patches can create

Ketek Side Effect Lawsuit

2011-10-12T19:18:54+00:00

Ketek Side Effect Lawsuit

Ketek Side Effect Lawsuits

According to the FDA, antibiotic drug Ketek increases the potential risk of life-threatening liver damage in patients. The drug, brand name of telithromycin and manufactured by Sanofi-Aventis, is prescribed as a treatment for moderate to severe respiratory infections, including pneumonia, sinusitis, and bronchitis. Ketek has been linked to sudden and fatal liver damage, drug-induced hepatitis, gastrointestinal side effects, and mild to moderate neurological disorders. It also causes false positive reading of patients tested for cocaine. In the past seven years, the FDA adverse reaction reporting system has received at least 20 reports of death caused by hepatic side effects of Ketek. The federal regulator has also added

Lioresal Side Effects Lawsuit

2011-10-04T21:45:57+00:00

Lioresal Side Effects Lawsuit

Lioresal Side Effect Lawsuits

Lioresal, brand name of Baclofen, is a popular muscular relaxant and antispasmodic drug. Manufactured by Basel-based Swiss pharma giant Novartis, Minnesota-based medicine technology giant Medtronic, and a number of generic manufacturers, the drug is administered in the form of tablets and intrathecal injections. Lioresal is approved as a medication for the treatment for muscle spasms, pain, rigidity, and cramping caused by injuries to the spinal cord, multiple sclerosis, and cerebral palsy. The drug is also considered helpful in fighting alcoholism and improving the quality of life of addicts. However, Lioresal has been linked to serious neurological dysfunction, reduced therapeutic response, drug abuse, and withdrawal symptoms, among other side effects.

The FDA approved Lioresal tablets in June 1992 and the intrathecal version in1996. The drug activates receptors in the brain that help in the production of gamma-aminobutyric acid, an inhibitory neurotransmitter and a key central nervous system depressant. The amino acid also helps muscles and ligaments located close to the spinal cord to prevent spasms and let the muscles relax. It ends spasticity and improves mobility. However, the adverse effects of Lioresal affect the central nervous system, psychiatric disorders, neurological response, and the thinking process of users. Patients taking the drug fail to remain awake and alert while driving, working, or doing any hazardous job. The drug can accelerate these problems in alcohol users.

Studies conducted by independent bodies have shown that Lioresal adversely impacts patients’ ability to deploy muscle tone for safety, balance, movement, and certain other essential activities. Lioresal side effects can be fatal for people with impaired kidney functions, bladder problems, liver problems, seizure-like disorders, Parkinson's disease, emotional instability, stomach ulcers, respiratory disorders, and elders with cerebrovascular problems.

Lioresal FDA Warnings

In March 2011, the FDA made safety labeling changes on Lioresal intrathecal. A safety alert issued by the federal regulator asked healthcare professionals to monitor patients taking the medication for withdrawal symptoms, intrathecal mass, and new neurological signs. According to the report of the Center for Drug Evaluation and Research, administration of Lioresal leads to decreased therapeutic response, neurological dysfunction, and pain caused by worsening spasticity.

In September 2009, the FDA

Wright Hip Replacement Implant Recall Lawsuit

2011-10-04T21:35:20+00:00

Wright Hip Replacement Implant Recall Lawsuit

Wright Hip Implant Lawsuit

Numerous complaints have been registered against Wright Medical Technology for marketing defective Profemur® Z hip implant device, which is reported to have a high failure rate of 11.2 percent. It has been reported that the hip implants fail merely three years after implantation – of every nine patients, one experiences problems with the defective Profemur device.

Patients complain that the main defect with Profemur® Z hip implant system lies with its flexible modular design, which means the neck can easily bend, degrade, break, fret, and ultimately fracture and fail. This creates problems for the patients, who experience stiffness in the groin and find difficulty in performing routine activities; difficulty walking or standing; and experience excruciating pain in the groin, thigh, hip, lower back. Most of the patients are required to undergo a revision surgery, which is even more painful and debilitating compared to the first hip replacement procedure. Surgeons, too, find it difficult to perform secondary procedure, which requires removal of the earlier implanted hip device and replacement with a new one. A number of patients complain that the Femoral Stem or Neck broke while they were performing normal activities, causing them debilitating injuries.

lawsuit Against Wright Medical Technology

Wright Medical Technology faces numerous product liability lawsuit for manufacturing and marketing defective products. Plaintiffs allege that the defendant company marketed the defective product claiming that these would last about 15 years. Contrary to this, the product lasts

Remicade Side Effect Lawsuit

2011-10-04T19:25:08+00:00

Remicade Side Effects Lawsuit

Remicade Side Effect Lawsuit

According to a safety alert issued by the FDA on September 6, 2011, Remicade and similar TNF inhibitor drugs put patients at an increased risk of infections from Legionella and Listeria bacteria. The federal regulator has updated boxed warnings on these drugs following receipt of more than 100 reports of pathogen infections, including 14 deaths, in the past decade caused by side effects of these immunosuppressive drugs. Most of the affected patients were within the 26-71 age group. Some of these patients suffered from serious viral, bacterial, and mycobacterial infections as early as within a month, while some others showed infection symptoms as late as 6 years after starting the TNF inhibitor drug therapy.

Of the 80 Legionella pneumonia cases reported, three patients died, four required mechanical ventilation, and five were put in intensive care units. There have also been 26 cases of serious meningitis, endophthalmitis, and sepsis infections, including seven deaths, caused by side effects of TNF inhibitor drugs. The FDA has asked healthcare experts to reconsider prescribing Remicade and similar drugs to patients above 65 years with immunosuppressant disorders or recurrent infections.

Remicade FDA Warnings

The FDA approved Remicade, brand name of infliximab, in 1988 for the treatment of Crohn's disease, psoriasis, and rheumatoid arthritis. The drug produced by Centocor, a subsidiary of pharma major Johnson & Johnson, is also certified as a medication for ankylosing spondylitis, psoriatic arthritis, and ulcerative colitis. However, the drug has been linked to decreased

Tegretol Side Effects Lawsuit

2011-10-04T19:09:36+00:00

Tegretol Side Effects Lawsuit

According to a research report published in the July 2011 issue of the Journal of the American Geriatrics Society, epilepsy drug Tegretol leads to reduced brain functioning and early death among the elderly. The study conducted by researchers at the Norwich-based University of East Anglia has found that the drug blocks acetylocholine, a key neurotransmitter responsible for anticholinergic activity of the brain. This creates cumulative effect on the functioning of the brain and puts people over the age of 65 at the increased risk of death.

Tegretol, brand name of carbamazepine, is manufactured by Swiss pharmaceutical giant Novartis. The anticonvulsant drug, approved by the FDA in 1974, is available in both tablet and liquid forms and is used as a medication for certain types of epilepsy-related seizures, bipolar disorder, and intense nerve pain linked to diabetic neuropathy and trigeminal neuralgia, and post-traumatic stress disorder. Tegretol side effects have been linked to reduced brain functions, neurological disorders, motor coordination impairment, stomach problems, cardiovascular problems, vision problems, thyroid problems, serious adverse cognitive anomalies, fatal skin reactions, and serious birth defects.

Tegretol Side Effects Warnings

In 1989, a report published in the New England Journal of Medicine highlighted the link between Tegretol and the incidence of birth defects. Researchers found that the drug interfered with fetal development when taken by expectant mothers and caused fetal malformations, such as craniofacial defects, developmental delays, and hypoplasia of the nails. Another study published in 2001 also warned that Tegretol and other anticonvulsants put a fetus at the risk of potential harmful side effects.

In December 2010, a research report published in the British Medical Journal claimed that women using of Tegretol during pregnancy are likely to have babies with major birth defects, including spina bifida, a birth problem that affects the development of spinal cord in the foetus. According to the report, the risk of spina bifida among new borns exposed to the drug is 2.6 times higher than unexposed infants.

In 2007, the FDA warned health care professionals about the risk of deadly skin reactions, such as toxic epidermal necrolysis, skin lesions, and the Stevens-Johnson syndrome caused by Tegretol side effects in people with the HLA-B*1502 gene variant, exclusively found in people of Asian origin. It recommended that doctors should test patients for the gene variant before prescribing the drug. The European patients with two genetic variants, HLA-B58 and HLA-A*3101, are also subject to the adverse reactions of the drug.

In January 2008, the FDA issued a safety alert warning consumers and doctors about the potential risk of suicidal thoughts or actions caused by the side effects of Tegretol and other antiepileptic drugs. Twelve months later, the FDA

Cymbalta Side Effects Lawsuit

2011-10-04T10:12:41+00:00

Cymbalta Side Effects Lawsuit

Cymbalta, an antidepressant drug manufactured by Eli Lilly, has been linked to severe psychiatric side effects, including the risk of suicidal thoughts and actions, in users. Postmarketing reports have also documented the increased risk of liver injury, cholestatic jaundice, and hepatitis in patients treated with Cymbalta therapy. Cymbalta, brand name of duloxetine, is used as a medication for major depressive and common anxiety disorders. It also helps in the treatment of fibromyalgia, diabetic neuropathy pain, chronic lower back pain, and musculoskeletal pain, including osteoarthritis. Cymbalta inhibits certain neurotransmitters in the brain, such as serotonin, which lead to sleep and memory disorders and cause depression.

A number of research studies have highlighted the fact that Eli Lilly’s Cymbalta does not entail more benefits compared to existing medications for stress urinary incontinence, depression, and diabetic neuropathy. The FDA has rejected Eli Lilly’s request to allow Cymbalta for stress urinary incontinence treatment, citing a large number of side effect reports linking Cymbalta to liver toxicity and suicides. Cymbalta discontinuation also leads to a number of withdrawal symptoms, including neurological problems, sensory disturbances, and psychiatric disorders.

Cymbalta FDA Warnings

In January 2010, the FDA warned Eli Lilly against false statements made by its representatives about the benefits of Cymbalta. The federal regulator was upset about claims made by the manufacturer about Cymbalta’s effectiveness in direct-to-consumer print advertisements without highlighting the associated risks in the main page.

In July 2011, the FDA alerted consumers and healthcare professionals about

Risperdal Side Effects Lawsuit

2011-10-04T09:56:25+00:00

Risperdal Side Effects Lawsuit

On September 22, 2011, an FDA advisory panel acknowledged that Risperdal and similar antipsychotics put children using these drugs at the increased risk of diabetes and severe weight gain. It recommended continued safety monitoring of Risperdal and admitted that Risperdal could cause potential long-term health problems in children. The expert panel also urged the FDA to carry out in-depth studies on these Risperdal side effects. It also sought label warnings on Risperdal, highlighting the risks.

Risperdal, known by its generic name risperidone, is manufactured by Janssen Pharmaceutica, a Johnson & Johnson subsidiary. The FDA approved this second generation antipsychotic in 1994 as a medication for schizophrenia, bipolar disorder symptoms, psychoses, and manic depression. Risperdal is also prescribed to treat irritability in people with autism and a number of psychological disorders. However, Risperdal has been linked to neuroleptic malignant syndrome, metabolic disorders, tardive dyskinesia, and death of

Byetta Side Effects Lawsuit

2011-09-28T07:29:13+00:00

Byetta Side Effects Lawsuit

According to a report published in the July issue of Gastroenterology and presented at the Lisbon meet of the European Association for the Study of Diabetes on September 14th, type 2 diabetes drug Byetta can put patients at the increased risk of pancreatitis, pancreatic cancer, and thyroid cancer. The study conducted by researchers at the Los Angeles-based Larry L. Hillblom Islet Research Center examined all the Byetta side effect reports that the FDA received between 2004 and 2009 and found that the drug could increase pancreatitis risk by six times and pancreatic cancer by three times compared to other diabetes medications. Researchers also discovered that patients treated with this drug were at a significantly higher risk of developing thyroid cancer.

The FDA approved Byetta, brand name of exenatide, in 2005 for the treatment of type 2 diabetes. Manufactured jointly by Eli Lilly and Amylin Pharmaceuticals, the drug is administered as an injection on the abdomen, thigh, or arm twice a day, 60 minutes prior to the first and last meals. The drug helps pancreas generate insulin and manage blood sugar levels. However, the adverse event reporting system of the FDA also received a number of complaints on hemorrhagic or necrotizing pancreatitis caused by Byetta in 2008. The drug has also been linked to gastrointestinal, neurological, renal, and metabolic side effects.

Byetta FDA Warnings and Complaints

In October 2007, the FDA issued an alert informing consumers about pancreatitis in diabetes patients caused by Byetta side effects. The federal regulator cited 30 reports of severe pancreatitis linked to the drug it had received. The new label changes on the drug reflected pancreatitis warning.

In 2008, the FDA

Cymbalta Side Effects Lawsuit

2011-09-26T18:25:33+00:00

Cymbalta Side Effects Lawsuit

Cymbalta Side Effects, Lawsuit

Cymbalta, an antidepressant drug manufactured by Eli Lilly, has been linked to severe psychiatric side effects, including the risk of suicidal thoughts and actions, in users. Postmarketing reports have also documented the increased risk of liver injury, cholestatic jaundice, and hepatitis in patients treated with the drug therapy. Cymbalta, brand name of duloxetine, is used as a medication for major depressive and common anxiety disorders. It also helps in the treatment of fibromyalgia, diabetic neuropathy pain, chronic lower back pain, and musculoskeletal pain, including osteoarthritis. The drug inhibits certain neurotransmitters in the brain, such as serotonin, which lead to sleep and memory disorders and cause depression.

A number of research studies have highlighted the fact that Eli Lilly’s Cymbalta does not entail more benefits compared to existing medications for stress urinary incontinence, depression, and diabetic neuropathy. The FDA has rejected Eli Lilly’s request to allow the drug for stress urinary incontinence treatment, citing a large number of side effect reports linking the drug to liver toxicity and suicides. Cymbalta discontinuation also leads to a number of withdrawal symptoms, including neurological problems, sensory disturbances, and psychiatric disorders.

Cymbalta FDA Warnings

In January 2010, the FDA warned Eli Lilly against false statements made by its representatives about the benefits of Cymbalta. The federal regulator was upset about claims made by the manufacturer about the drug’s effectiveness in direct-to-consumer print advertisements without highlighting the associated risks in the main page.

In July 2011, the FDA alerted consumers and healthcare professionals about

Lyrica Side Effects Lawsuit

2011-09-19T21:25:49+00:00

Lyrica Side Effects Lawsuit

Pfizer’s antiepileptic drug Lyrica has been linked to reduced brain functioning, psychiatric side effects, including suicidal behavior, withdrawal symptoms, and rare but serious allergic reactions. The FDA approved the drug, known by its generic name pregabalin, in 2004 as a treatment for epilepsy, neuropathic pain in diabetics, spinal cord injury, and severe neuralgia caused by herpes zoster. In 2007, the FDA allowed Pfizer to market Lyrica as a medication for fibromyalgia rheumatoid disorders. The anticonvulsant drug slows down the brain impulses responsible for seizures.

In 2009, Pfizer admitted that it had illegally promoted Lyrica and three other drugs with false claims and misbranded them "with the intent to defraud." Lyrica impacts the whole body adversely and create digestive, nervous, and respiratory disorders. Patients using the drug are likely to suffer from lack of strength, breathing problem, muscle coordination problems, and accidental injury. The product label on Lyrica also carries warnings for suicidal behavior, angioedema or head, neck and throat swelling, respiratory emergency of the highest degree, increase in seizures, withdrawal problems, neurological disorders, risk of tumors, and allergies. The drug can

Levaquin Side Effects Lawsuit

2011-09-16T18:54:47+00:00

Levaquin Side Effects Lawsuit

A New Jersey court in Atlantic City took up two Levaquin lawsuits for trial on September 6, 2011. The trial is one of more than 3,000 Levaquin lawsuits filed across the United States. The plaintiffs have sued Johnson & Johnson for its failure to adequately warn consumers and healthcare professionals about the risk of tendon ruptures and other injuries associated with Levaquin side effects.

The FDA allowed Johnson & Johnson to market antibiotic Levaquin, brand name of levofloxacin, in December 1996. The drug is used for the treatment of bacterial infections affecting the skin, kidney, sinus, prostate or any other body part, bronchitis, and pneumonia. However, the antibiotic puts users at an increased risk of long-term, chronic, and fatal health problems, such as tendon ruptures, neurological disorders, liver damage, kidney impairment, allergic reactions, and heart problems. Levaquin side effects have also been linked to Stevens-Johnson syndrome and acute pancreatitis in patients.

Levaquin FDA Warnings and Complaints

In 2004, the FDA ordered for label changes for Levaquin, alerting users about

Forteo Side Effect Lawsuit

2011-09-15T15:53:27+00:00

Forteo Side Effect Lawsuit

Osteoporosis drug Forteo, manufactured and marketed by Eli Lilly, has been linked to the increased risk of bone cancer, muscle cramps, and neurological disorders in patients. The FDA approved the drug in November 2002 for the treatment for osteoporosis in postmenopausal women and men facing serious risk of vertebral and nonvertebral fractures. Forteo contains teriparatide, a recombinant parathyroid hormone that regulates phosphate and calcium metabolism in kidney and bones. The drug increases bone density, stimulates bone formation, and enhances bone strength, which help in preventing fractures. The drug is administered as an injection for a maximum of two years. Forteo has been denounced by consumer advocacy groups on the safety issues. It has been subjected to many side effect lawsuits throughout the United States.

Forteo Black Box Warning

Forteo carries a FDA black box warning, the strongest possible alert, for putting patients at

Smith Nephew Hip Replacement Implant Recall Lawsuit

2011-09-13T16:42:01+00:00

Hip Replacement Recall Lawsuit

Smith & Nephew Birmingham Hip Replacement Recall

In 2007, Smith & Nephew recalled about 185 Birmingham hip resurfacing system implants over improper packaging by a subcontractor. As a result of the packaging error, it was reported that different sizes of acetabular cups were mixed and mislabeled. A number of patients have complained of having received wrong-sized hips, which has forced them to undergo a revision surgery to remove and replace the improperly fitting hip that has been wearing out quickly and causing extreme complications for them.

Smith & Nephew blamed the error on a subcontractor that mislabeled thedevices, which caused a mismatch between the two hip implants. This meant that patients requiring a hip device of a different size received a mislabeled hip implant, which resulted in their hip implant failure.
The mismatched pieces result in loosely fitting implants. Patients that have undergone hip replacement surgery using Smith & Nephew Birmingham hip device are advised to consult their doctors and go for a post-operation X-ray to confirm whether they have properly fitting implants.

In case they are found to have the improperly fitting hip device, revision surgery is the only solution.

Recently, the

Humira Side Effects Lawsuit

2011-09-07T19:09:33+00:00

Humira Side Effects Lawsuit

Humira Side Effect Lawsuit

Our interpretation of research done by researchers at the Dallas-based Baylor Research Institute, leads us to believe in our opinion that Humira and other popular psoriasis drugs may put patients at an increased risk of heart attacks, stroke, and consequent death. The disclosure came a few months after the FDA issued a safety alert on 14 April 2011, linking the drug to a rare type of blood cancer in children and young adults. Humira, a TNF inhibitor, carries black box warning about fatal blood cancer and fungal infections.

The FDA permitted Illinois-based Abbott Laboratories to market Humira, brand name of adalimumab, in 2003 as a medication for severe rheumatoid arthritis. The drug, the first human monoclonal antibody, has been approved for use only in cases where other anti-rheumatic drugs are found to be insufficient. In 2007, the FDA allowed Humira to be used for the treatment of severely active Crohn's disease in adults. However, a number of studies have linked the drug to serious blood disorders, fungal and virus infections, liver injury, central nervous system problems leading to demyelinating disorders, cardiac failure, and tuberculosis. It suppresses TNF, a cytokine produced by white blood cells, which renders the immune system ineffective in the fight against new infections.

Humira Complaints and FDA Warnings

In 2005, the FDA disclosed that it had identified at least nine cases of neurological disorders caused by Humira within the first two years of its introduction. Two of these complaints were related to optic neuritis, inflammation of a nerve, resulting in pain and loss of function. According to a research report published in the Journal of the American Medical Association on May 17, 2006, Humira side effects put users at the risk of developing certain types of cancers.

Estraderm Side Effect Lawsuit

2011-09-05T22:56:55+00:00

Estraderm Side Effect Lawsuit

Estraderm skin patch manufactured by Novartis has been linked to fatal side effects, including cardiovascular risks. Approved by the FDA in 1986, the skin patch contains transdermal estradiol, a form of female sex hormone estrogen. It releases estrogen into the body through a membrane when kept continuously attached to the skin. The skin patch is used as short-term hormonal replacement therapy for the treatment for menopause symptoms, such as vagina dryness, burning, bleeding, and itching sensation, ovarian disorders, and osteoporosis in postmenopausal women. The drug helps the body overcome oestrogen deficiency.

Estraderm side effects lead to abnormal vaginal bleeding, liver cholestasis, skin problems, nervous system problems, and increased risk of cardiovascular diseases. The drug has also been linked to activation of certain oncogenes and development of breast and ovarian cancers in users. A study conducted by the Women's Health Initiative disclosed in 2004 that the use of Estraderm for a longer duration puts postmenopausal women at a significantly higher risk of dementia. The report also highlighted other side effects of the drug, including myocardial infarction, deep vein thrombosis, stroke, and breast cancer, in postmenopausal women. Most of the women monitored during the study had taken the hormonal replacement therapy for four to five years.

Avastin Eye Infection Lawsuit

2011-09-03T22:17:58+00:00

Avastin Eye Infection Lawsuit

Avastin Blindness Lawsuit

If you or a loved one were affected by Avastin and would like a free case review by the lead attorney handling these cases , Please submit your case by clicking the free case review button above or by calling the the lead firm directly at (800) 748 - 7115

Roche’s Avastin, the best selling cancer drug in the world, has been linked to blindness and outbreak of serious eye infections in Florida, Miami, and Tennessee. The Department of Veterans Affairs has confirmed on September 1st that five patients went blind in August 2011 after receiving Avastin injections at a Los Angeles-based medical center while undergoing treatment for age-related macular degeneration. The disclosure came two days after the FDA public health alert reported 12 incidents of vision loss caused by the drug in the Miami area. According to the Tennessee Valley Healthcare System, four Nashville patients have also suffered from infections and lost vision after receiving Avastin vials for eye diseases.

Prempro Side Effect Lawsuit

2011-08-31T10:08:45+00:00

Prempro Side Effect Lawsuit

Prempro Side Effect Lawsuit Attorney

On June 22, 2011, the Supreme Court rejected Pfizer’s appeal against $58 million compensation awarded by a jury to three Nevada women in a Prempro lawsuit. The plaintiffs suffered from breast cancer after they received the Prempro hormone replacement therapy. The judgment came within a month after Pfizer earmarked $722 million to settle Prempro lawsuits seeking compensation for breast cancer side effects.

Prempro by Wyeth, a unit of Pfizer, is a combination of Provera and Premarin, two drugs produced by the same manufacturer. It contains conjugated estrogens and medroxyprogesterone, two sex hormones that regulate ovulation and menstruation in females. Prempro hormone therapy helps in the treatment of menopause symptoms, such as vaginal dryness, burning sensation, irregular menstruation, hot flashes, and prevention of osteoporosis, which causes thinning of the bones. However, the drug increases the risk of patients developing heart disease, blood clots, breast and uterus cancer, dementia, and

Biomet Hip Replacement Implant Recall

2011-08-31T03:05:52+00:00

Biomet Hip Replacement Implant Recall

Biomet Hip Replacement Implant Recall System

In February 2001, the FDA announced that Biomet, US manufacturer of artificial hips, had made a voluntary recall of its hip replacement system following discovery of defects in the zirconia ceramic femoral heads. The ceramic femoral head components had been produced by the French manufacturer Saint Gobain Desmarquest, which distributes zirconia ceramic femoral heads to the orthopedic industry throughout the world.

Biomet recalled the defective product from the market after it found that the device was vulnerable to fracture at a higher than expected rate, causing failure of the hip implant system within 13 28 months. The recall applies to nine lots of the non implanted ceramic femoral head components, also known as Prozyr® Zirconia Heads, produced from January 1998 to September 1999, when Saint Gobain Desmarquest changed its manufacturing process, especially the heating procedure of the ceramic heads. However, the change is believed to have caused a negative impact on the ceramic femoral head components, which were found to become unstable soon after implantation.

Several other manufacturers of hip implants used this defective component in their hip replacement systems, including DePuy Orthopedics, Stryker Howmedica Osteonics, Encore Orthopedics, Smith & Nephew Inc., Osteoimplant Technology, Apex Surgical, and Zimmer Inc. The batch number of the recalled ceramic femoral head batches has the prefix "TH." The recall only applies to ceramic femoral heads produced since the early 1998. It does not affect any femoral heads made of alumina ceramic.

Following the Biomet recall, all these companies followed suit and withdrewtheir artificial hip replacement systems from the market, saying that the product could fail and fracture, following which the patient would need to undergo a replacement and revision surgery. Even surgeons complain that they find it hard to remove and replace the defective components.

The FDA stated that there were problems with the ball portion of the artificial hip joint, which connects the pelvis and the femoral stem. Reports claim that the ball portion of the artificial hip joint is faulty, which has a propensity to become unstable and thus cause fracture. There are many cases where patients have reported to have heard a popping sound from their hip just before the device fractured, following which they started experiencing excruciating hip and groin pain.

The FDA received a number of reports that the components

DePuy Hip Replacement Recall Lawsuit

2011-08-29T22:28:58+00:00

DePuy Hip Replacement Recall Lawsuit

DePuy Pinnacle Hip Replacement Implant Ultamet Recall

Following the DePuy ASR recall, there have been numerous complaints that DePuy Pinnacle hip implant is causing similar problems when used with a metal liner. Patients and doctors demand that, with more than 1,300 adverse event reports filed with the FDA against Pinnacle hip implant, it is high time DePuy Orthopedics issued a recall for the device, which is reported to have a 13 percent failure rate. The device is linked to potential side effects, including severe pain, hip dislocation, hip replacement failure, metal toxicity, and need for a revision surgery in many cases.

The FDA approved the DePuy Pinnacle® Ultamet® metal acetabular inserts in 2001. However, not all Pinnacle hip devices are metal on metal, but the metal bearing surface poses the risk of revision compared to other bearing surfaces, including plastic, polyethylene, ceramic, and polymer. The Pinnacle metal on metal hip replacement system with a femoral head, particularly the one that is more than 32 mm, poses a threat of revision surgery. Though the Pinnacle Ultamet does not have as high a failure rate as ASR implants, a large number of incidences of

Zimmer Durom Hip Replacement Implant Lawsuit

2011-08-24T20:03:47+00:00

Zimmer Durom Hip Replacement Implant Lawsuit

Zimmer Durom Hip Replacement Implant

In 2008, Zimmer Holdings suspended sale of Durom Acetabular Cup following numerous complaints of a high implant failure rate. Since 2006, when Durom Cup came to be used in the United States, numerous complaints and lawsuits have been filed against Zimemr Holdings. Most of the lawsuits filed against Zimmer allege that the defendant did not disclose the risks associated with the hip implant cup when it marketed the product. However, Zimmer continues to deny the allegations, precisely blaming the surgeons for the high hip implant failure rate. Many patients have complained that the Durom Cup failed within two years of implantation, as a result of which, they had to bear severe pain and undergo a revision surgery.

Patients complain of pain and stiffness following their hip replacement surgery with Durom Cup. They allege that they experience so much stiffness and sharp pain in the groin that they cannot walk properly. Most of the patients also allege that they even find it difficult to come down the stairs.

Zimmer Durom Cup Dangers

The Durom Cup had been implanted in more than 12,000 patients in the country from 2006 to 2008. According to reports, about 11 percent of the Durom Cup implants failed in the first two years. However, Zimmer claims that the product can last for 15 years, saying that the metal hip replacement system is far more durable than traditional implants.

In fact, the Durom Cup is a metal-on-metal hip replacement system, with multiple metal components designed to fit into a “ball and socket” formation. As the ball rotates and rubs against the cup-like socket, it sometimes presses against the edge of the cup, thus generating a large volume of microscopic metal shavings into the patient’s bloodstream. The metallic debris can be absorbed by the soft tissue, resulting in

Hip Replacement Implant Recall Lawsuit

2011-08-23T21:54:19+00:00

Hip Replacement Implant Recall Lawsuit

DePuy Defective Hip Replacement Implant Recall

DePuy Orthopedics has issued a recall for two of its hip replacement systems following reports indicating a higher-than-normal implant failure rate. DePuy recall came after more than expected number of people had to undergo secondary surgery due to hip implant failure. Since their approval in 2003, DePuy ASR hip implants have been used in over 93,000 hip replacement surgeries. Hip implants generally last 15 years; however, many patients have complained that their artificial hips lasted only two or three years, following which they were required to undergo expensive and painful revision surgeries, which caused them more pain and loss of money.

The FDA has received over 300 complaints against DePuy Orthopedics regarding defective hips. Complaints against DePuy started surfacing in 2009; however, DePuy issued a recall only after a long wait of about 18 months, after its defective product had caused more harm to many other patients throughout the country.

Hip Replacement Implant Metal Toxicity

DePuy has recalled both products because of their high failure rate.DePuy’s metal-on-metal hip products use a metal ball and metal cup, which are installed in the place of the natural ball and socket hip. When DePuy launched its new metal-on-metal hips, it claimed that the product was stealthier than traditional hips made of metal and plastic. However, it ignored the risk of metal toxicity posed by metal-on-metal hip products. Even a number of complaints registered against DePuy claim that the metal-on-metal hip implants caused metal toxicity in many patients.

Analysts believe that when metal ions rub against each other as a result of friction and movement, these metal particles spread into the surrounding tissue and bloodstream. Further, these metal ions do not allow the cup to bond properly with the bone, causing cup loosening and hip fracture, besides other complications, including persistent pain, inflammation, discomfort, lethargy, dizziness, headache, gastrointestinal problems, food allergies, muscle and tissue damage, bone fractures, and Pseudotumors.

Metal toxicity causes heart problems, skin rashes, nerve damage, depression, numbness, loss of sensory and

Actos Side Effects Lawsuit

2011-08-19T18:09:46+00:00

Actos Side Effects Lawsuit

Actos Side Effects Lawsuits

The FDA has updated label warnings on diabetes drug Actos, informing patients and doctors about the risk of bladder cancer from this drug. According to the drug safety advisory issued by the federal regulator on August 5, 2011, patients taking Actos for more than a year are at a greater risk of developing bladder cancer. It advised healthcare professionals against prescribing the drug to people with a history of bladder cancer or symptoms, such as blood in urine, pain while urinating, and pain in the lower abdomen.

Actos Side Effects Complaints

Actos, known by its generic name pioglitazone, is an oral diabetes medicine marketed by Takeda and Eli Lilly pharmaceuticals in the U.S. market. Approved in 1999, it helps control blood sugar levels in patients with Type 2 diabetes. Though research studies funded by the manufacturer claim the drug has helped reduce the number of diabetes cases by 72 percent, the side effects outweigh the benefits. Actos leads to several fatal side effects, including fluid retention and cardiovascular problems. In 2003, a study carried out by the Mayo Clinic linked Actos to swelling in the feet, fluid retention in the lungs, shortness of breath, and congestive heart failure.

In September 2010, the FDA ordered a comprehensive review of the drug safety following disclosures that

Fosamax Side Effects Lawsuit

2011-08-19T00:25:00+00:00

Fosamax Side Effects Lawsuit

Fosamax Side Effects Jaw Lawsuit

Fosamax, brand name of Alendronic acid, is used for the treatment of osteoporosis. Licensed in 1995, the drug has been used by more than 10 million patients for the treatment of bone diseases, which cause loss of bone mass, including advanced cancer, post-menopausal osteoporosis, and Paget’s disease.

Fosamax FDA Warning

In 2004, the Food and Drug Administration asked the Fosamax manufacturer, Merck & Co., to place a warning about the side effects of the drug. But patients that used the drug allege that Merck did not inform them about the risk of jaw necrosis posed by the drug. Since 2003, more than 3,000 jaw necrosis cases have been reported among the users of bisphosphonate. The FDA again issued a warning in 2010 for Fosamax users that prolonged use of the drug posed a risk of thigh fracture.

Fosamax Lawsuit

The Fosamax manufacturer faces over 900 lawsuits throughout the country over the side effects of the drug. Recently, a federal district judge in Manhattan rejected the defendant’s plea to dismiss a Fosamax lawsuit. In the lawsuit, the plaintiff from Indiana alleged that administration of Fosamax for more than eight years had caused her jaw damage.

Fosamax Side Effects

A large number of studies link Fosamax to Ostenecrosis of the jaw. A research conducted by the School of Dental Medicine, Harvard University, proves that bisphosphonate drugs are linked to Osteonecrosis of the jaw. The study claims that prolonged use of the drug by cancer patients causes Osteonecrosis of the jaw in about 6-10 percent of the patients. Jaw necrosis results in loose teeth, numbness, severe jaw pain, exposed bone, gum infection, blood clotting disorders, swelling, and anemia.

Osteonecrosis of the Jaw

Fosamax is known to prevent the breakdown of bone cells so as to help their rebuilding, thus improving bone density. This brings down the risk of fractures. However, the drug poses a risk of infection and disease to the bones, particularly in the mouth. There is an increased risk of infection in the mouth and Osteonecrosis of the jaw if the bacteria reach the jawbone. This means the body will not be able to resist the infection and become vulnerable to disease.

A number of patients complain that prolonged use of Fosamax has made them vulnerable to jaw necrosis, following which they had to undergo expensive dental procedures. It is also reported that any dental procedure poses an increased risk of wear and tear of the Temporomandibular Joint. This further threatens full decay of the bone tissue, which requires a dental procedure necessitating complete removal of the jaw.

Studies claim that patients treated with chemotherapy or radiation therapy are more at the risk of jaw necrosis.

Fosamax Bone Fracture

Many studies claim that prolonged use of alendronate poses a risk of low-impact femoral fractures, particularly fracture of the upper thigh bone. The thigh bone becomes brittle with the use of Fosamax, which prevents the cells from contributing to bone remodeling. Numerous studies claim that Fosamax results in an increased number of multinucleated osteoclasts.

Cancer

Cancer patients are more vulnerable to Fosamax side effects. Studies claim that cancer patients treated with intravenous dose of Fosamax are more likely to develop side effects than those who take the drug orally.

Fosamax Gastrointestinal Tract

According to an FDA report, bisphosphonate drugs, including alendronate, cause ulceration of the esophagus, thus posing the risk of esophageal cancer.

Common Fosamax Side Effects

Fosamax might cause severe allergic reactions in some patients, resulting in itching and rashes. Chest pain; tightness in the chest; difficulty breathing; painful swallowing; pain in the mouth; swelling in the throat, lips, jaw, tongue; coughing; persistent heartburn; blood vomiting; swelling of the hands; persistent stomach pain; sore throat; constipation; nausea, vomiting, dizziness, stomach pain; diarrhea; toxic epidermal necrolysis; severe pain in muscles, bones, joints are some of the common side effects of the drug.

Fosamax Precautions

Take Fosamax at least 30 minutes with empty stomach in the morning.
Take Fosamax with a full glass of water; avoid using the drug with tea, coffee, juice, or mineral water.
Do not take any other medicine or antacids prior to or after the administration of Fosamax.
Avoid taking the drug if you find it difficult to sit upright or stand for at least half an hour because in such a scenario, the drug poses a risk of problems in the stomach and esophagus. You must stay upright for at least half an hour after administration of the drug.
Check your parathyroid hormone level before taking Fosamax if you are an elderly woman to prevent osteoporosis. Exceedingly low levels of vitamin D threaten to increase parathyroid hormone levels.
Do not take Fosamax if you are sensitive to alendronate.
Avoid Fosamax if you have low blood calcium levels.
Do not take Fosamax if you suffer from a severe kidney disease.

Further, pregnant women must avoid taking any bisphosphonate drug, including Fosamax, which is a pregnancy category C drug,and can thus be unsafe for the fetus and the mother. Keep your doctor informed if you are expecting or plan to conceive in the near future so that he does not prescribe the drug. Also, if you are taking a Fosamax dose, keep your dentist informed if he suggests any dental procedure to avoid any side effects

Provera Side Effects Lawsuit

2011-08-17T19:02:14+00:00

Provera Side Effects Lawsuit

Provera Side Effects Lawsuits

Provera, manufactured by Upjohn Pharmaceuticals, a unit of Pfizer, has been linked to breast and uterine cancer, blood clot disorder, and a number of other side effects. The drug made up of medroxyprogesterone acetate is used to treat menopausal symptoms, abnormal menstrual cycle changes in females, irregular menstrual, uterine bleeding, and premenstrual tension. It regulates secretion of progesterone, a female sex hormone regulating ovulation and menstrual periods. The drug also prevents overgrowth of the uterine lining caused by estrogen replacement therapy.

Provera Side Effects Warnings

A major study the National Institute of Health conducted in 2002 linked Provera and similar hormone drugs to a significant increase in the risk of cardiovascular problems, blood clots, and breast cancer. The study advised patients having epilepsy, migraines, seizures, asthma, heart problems, and diabetes to avoid the medication or consult the doctor. According to another research by Women's Health Initiative Memory Study, elderly postmenopausal women treated simultaneously with the drug and the estrogen therapy are more likely to develop dementia.

The FDA has categorized Provera under the pregnancy category D. The drug can cause minor birth defects in children if expectant mothers are administered the drug. There have been reports linking the drug to genital abnormalities in babies born from mothers who took the drug during the first trimester of pregnancy. Male babies born from such mothers are likely to suffer from hypospadias, a condition in which the penis opens underside than the tip. Clitoris enlargement and labia fusion are the foremost problems the female fetus is likely to have due to the drug side effects.

Premarin Side Effects Lawsuit

2011-08-17T01:45:14+00:00

Premarin Side Effects Lawsuit

On August 4, 2011, the Supreme Court of British Columbia allowed a class action lawsuit against Pfizer’s subsidiary Wyeth Pharmaceuticals, the maker of hormone drug Premarin, to proceed. The lawsuit originally filed by Dianne Stanway, a Sechelt native, represents all women who developed breast cancer due to the use of the drug between 1977 and 2003 to ease symptoms of menopause. The plaintiffs have accused Wyeth Canada of marketing the drug without proper safety research and warning for patients.

Premarin, a mixture of estrogen hormones, has been marketed by Wyeth since 1942 as a hormone replacement therapy for the treatment of menopause symptoms, such as vaginal dryness, itching, irritation, burning, and hot flashes. Its primary goal is to boost production of sex hormone estrogen in women with ovarian failure or those lacking natural estrogen in their body. The drug therapy is also prescribed to prevent osteoporosis in postmenopausal women and used in the cancer treatment in both men and women.

Premarin Side Effect Complaints

Premarin has been linked to heart problems, breast cancers, blood clot, vaginal bleeding, liver disease and birth defects. The first comprehensive research report on the drug was made public in December 1975. The study, conducted by Ralph Nader’s Health Reserach Group, discovered that taking the drug on long-term basis put patients at the risk of uterine cancer. The findings were presented to the Advisory Committee of Gynaecology and Obstetrics constituted by the FDA.

In 1976, the FDA directed the manufacturer to attach a label warning to the drug informing users about

MultiHance Side Effects Lawsuit

2011-08-15T17:09:16+00:00

MultiHance Side Effects Lawsuit

MultiHance Injection Side Effects Lawsuit

MultiHance, brand name gadobenate dimeglumine, is a gadolinium-based contrast injection manufactured by the Bracco Diagnostics Inc to be used during MRI diagnostic tests to make it easier for physicians to distinguish blood vessels and arteries on the films. However, the drug is linked to the development of Nephrogenic Fibrosing Dermopathy and Nephrogenic Systemic Fibrosis in patients suffering from a chronic kidney disease or acute kidney injury. NFG is a debilitating condition that causes thickening of skin, which can be severely disabling, might impair mobility and also involve fibrosis of other organs. In some cases, NFG might also become fatal.

MultiHance Injection Dangers

The Federal Drug Administration approved MultiHance in November 2004 to be used during MRI scans to identify blood vessels and arteries. However, following numerous complaints that the drug caused Nephrogenic systemic fibrosis or Nephrogenic Fibrosing Dermopathy, the federal agency issued a public health advisory in 2006, warning kidney patients to avoid administration of MultiHance. Further, in 2007, the FDA added a "black box" warning to the drug for the same reason.

The drug is known to cause excessive scar tissue on the internal organs in patients suffering from systemic disorder, which impairs mobility. This can even turn fatal for the patient, with no effective treatment available.

Nephrogenic Systemic Fibrosis

Patients suffering from acute renal insufficiency are most at the risk of nephrogenic systemic fibrosis if administered any of the Gadolinium-based contrast agents, including MultiHance, because of the hepato-renal syndrome. MultiHance is known to release gadolinium directly into the blood, whose residue continues to remain in the body of patients suffering from chronic renal insufficiency, causing fatal Nephrogenic Systemic Fibrosis. The condition involves development of excessive fibrous connective tissues, causing burning sensation, stiff skin, and swollen lower extremities, besides creating dermal and epidermal problems. NSF is a progressive disorder that causes

Mirapex Side Effect Lawsuit

2011-08-14T16:57:08+00:00

Mirapex Side Effect Lawsuit

Mirapex Side Effect Lawsuits

Mirapex, a prescription drug manufactured and distributed by Pfizer and Boehringer Ingelheim Pharmaceuticals, was approved by the FDA in 1997 for the treatment of Parkinson’s disease. The drug has also been used to treat the symptoms of restless legs syndrome since 2006 and cluster headache and sexual dysfunction in selective cases. Parkinson’s disease destroys neurons responsible for producing dopamine, a neurotransmitter in our body. Mirapex stimulates dopamine receptors and restores signals that counter signs and symptoms of the neurodegenerative disorder. According to studies and post-marketing reviews, the drug causes adverse effects, including sedation, somnolence, body aches and pains, overeating, weight loss, insomnia, twitching, and unusual tiredness or weakness.

The drug causes intense expression of D3 receptors in brain regions controlling mood, behavior, and reward, which results in strong urges. A number of lawsuits have been filed against the manufacturer, claiming that the plaintiffs suffered from hallucinations, orthostatic hypotension, and compulsive behaviors, such as gambling obsession, excessive shopping, and hypersexuality due to the use ofMirapex. It has also been linked to excessive drowsiness, sudden sleep, clinical depression, restlessness, and fibromyalgia rheumatoid disorders.

Mirapex Complaints

According to a research report published in the Archives of Neurology in May 2010, Mirapex can triple the risk that users develop impulse-control problems. The study carried out by the Philadelphia University medical center covering more than 3,000 Parkinson’s patients using dopamine discovered one or more impulse-control problems, such as compulsive gambling, enhanced sexual behaviors, binge eating and shopping sprees, in Mirapex users. A paper presented at the International Congress of Parkinson’s Disease and Movement Disorders in Chicago in June 2009, also linked the drug to impulse-control disorders and behavioral side effects. The report highlighted findings about U.S. and Canadian patients treated for Parkinson’s disease at 46 medical centers.

Enbrel Side Effects Lawsuit

2011-08-12T02:20:22+00:00

Enbrel Side Effects Lawsuit

Enbrel Side Effects

According to a public health alert issued by the FDA in April 2011, use of popular arthritis drug Enbrel can lead to blood cancer. Enbrel, trade name of Etanercept, is a TNF inhibitor co-marketed by Pfizer and Amgen in North America. Available in both powder and premixed liquid form, it was one of the most sold drugs in the U.S. market in 2010 with sales exceeding $3 billion. Enbrel is known to treat autoimmune disorders, such as plaque psoriasis, rheumatoid and psoriatic arthritis, excessive inflammation, and ankylosing spondylitis, in adults and prevent damages to joints caused by these diseases. It helps in the treatment of juvenile rheumatoid and polyarticular idiopathic arthritis in children above 2 years of age.

The immune system mistakenly attacks and destroys its own cells in people suffering from autoimmune problems. Enbrel prevents this by reducing the production of a certain protein that helps the immune system fight invaders. However, such action by the drug leads to serious and fatal side effects. The decrease in the number of white blood cells caused by the drug puts patients at a great risk of fatal infections. Teenagers and young adults with ulcerative colitis are likely to develop a rare, fatal cancer, which affects the liver, lymph, bone marrow, and spleen. Enbrel has also been linked to night sweats, loss of appetite, breathing problems, rapid heart rate, jaundice, and

Zelnorm Side Effects Lawsuit

2011-08-11T09:41:12+00:00

Zelnorm Side Effects Lawsuit

Novartis withdrew its constipation drug Zelnorm from the market on March 30, 2007 after the FDA discovered serious cardiovascular side effects associated with the drug. Zelnorm, brand name of Tegaserod, was approved in 2002 as a short-term relief for women with severe, irritable bowel syndrome and people below 65 years suffering from chronic constipation. The drug enhances the action of serotonin, a neurotransmitter, in the intestine which accelerates the bowel movement of stools. However, research conducted on the efficacy of the drug have linked it to an increased risk of cardiovascular problems, such as heart attacks, congestive heart failure, strokes, angina, and other side effects.

Zelnorm Lawsuit Warning and Recall

The FDA asked Novartis to pull out the drug after analyzing the results of as many as 29 clinical studies on the drug. The federal regulator found that while the drug was only 6 percent more effective than a sugar pill in treating irritable bowel syndrome, patients were eight times more prone to developing cardiovascular problems due to Zelnorm side effects. Studies also indicated that drug users were three times more likely to develop ovarian cystic tumors and five times at the risk of surgery for abdominal problems.

Zelnorm approval was delayed by a year after a number of scientists and consumer group Public Citizen voiced strong reservations against FDA’s approval of the drug. According to them, the side effects of the drug outweighed its benefits. In April 2004, the federal regulator issued a public health advisory that linked Zelnorm to serious cases of diarrhea, ischemic colitis, and other medical conditions caused by reduced blood flow to the intestines. The FDA warned that side effects of the drug could lead to low blood pressure, hospitalization for rehydration, loss of body fluid, passing out spells, and other serious consequences of diarrhea. Patients feeling intense stomach pain or lightheadedness due to diarrhea are advised to stop taking the drug with immediate effect. The label revisions called for discontinuation of Zelnorm therapy to patients with

Vaginal Mesh Lawsuit

2011-08-10T17:17:17+00:00

Vaginal Mesh Lawsuit

As concerned citizens and advocates of justice for all, we here at doihavealawsuit.com are frequently exposed to some of the most shocking data on on implant recalls as well as medical device and pharmaceutical drug recalls. Our extensive investigations into products such as the vaginal mesh and transvaginal mesh will often times uncover health risks or potential failure in other mesh products as well as other drug products.

Our affiliated vaginal mesh lawsuit attorneys are acknowledged practitioners of recall law and some of the most feared attorneys in America by corporations and implant or device manufacturer's whom opted not to put your safety first.

If you or a loved one are a victim of these faulty vaginal mesh implants, we recommend contacting an attorney right away to begin the process of your vaginal mesh lawsuit.

Simply click the submit my case button at the top left corner of this page or call the lead firm handling these complicated cases by calling (800) 748-7115 directly

Be safe.

Were on your side

Turkey Recall Lawsuit

2011-08-09T22:21:50+00:00

Turkey Recall Lawsuit

Cargill Meat Recalls Turkey Meat

Cargill Meat Solutions has recalled 36 million pounds of ground turkey meat potentially contaminated by salmonella bacteria. The second biggest U.S. meat recall was prompted after a nationwide salmonella outbreak resulted in the death of one consumer in California and hospitalization of 76 others in 26 states. The illness caused by salmonella outbreak was first reported on March 7th. It spread from coast to coast by mid-July. The Food Safety and Inspection Service of the U.S. Department of Agriculture issued a public health alert on July 29th confirming the link between the illness caused by the bacteria and the ground turkey meat. It ordered for the investigation after some leftovers from turkey meat recovered from a victim’s house were found infected with salmonella bacteria.

The USDA informed the Cargill management of its findings on August 3rd that triggered the recall. According to a press release, the Minnesota-based company is recalling all fresh and frozen turkey products processed at its plant in Springdale, Arkansas, between February 20th and August 2nd 2011 for possible infection from the strain of salmonella. The affected packages bear the code "Est. P-963" and are sold under different meat and grocery store brands, such as Honeysuckle White, HEB, Riverside Ground Turkey, Safeway, Natural Lean Ground Turkey, Kroger, Fit & Active Lean Ground Turkey, Randall's, Tom Thumb Spartan Ground Turkey, Giant Eagle, and Shady Brook Farms Burgers.

Salmonella Health Hazards

According to the Center for Disease Control and Prevention, the ground turkey products are contaminated with Salmonella Heidelberg bacteria that can resist multiple drugs, including antibiotics. It can cause infection, resulting in diarrhea, abdominal cramps, and acute fever within 12 hours of entering the intestine. Though the sickness lasts for a week, it can cause fatal health problems when the bacteria spread to bloodstream and other vital organs in the body. Severe salmonella infection can cause death of infants, seniors, and those with impaired immune systems. The infection caused by the bacteria has also been linked to a type of rare kidney failure, known as hemolytic uremic syndrome.

Previous Recalls by Cargill

Cargill and its subsidiaries have made 10 recalls since 1993. The present recall is

Paxil Side Effects Lawssuit Attorney

2011-08-01T08:22:00+00:00

Paxil Side Effects Lawssuit Attorney

Paxil Side Effects Lawsuit

A complaint made by a Pennsylvania professor to the U.S. Office of Research Integrity on July 11, 2011 has accused GlaxoSmithKline and two academicians of collaborating to publish a biased report on the efficacy of Glaxo's antidepressant drug Paxil in 2001. According to the complainant, the report was ghostwritten, lacked proper research on the claims to treat patients suffering from depression and bipolar disorder, and downplayed the side effects of Paxil.

GlaxoSmithKline’s Paxil, brand name of paroxetine, was approved by the FDA in 1992 for the treatment of obsessive-compulsive disorder, panic disorder, depression, and anxiety disorder. However, Paxil has been linked to toxicity, weight gain, sexual dysfunction, risk of suicidal behavior, serotonin syndrome, hypomania, discontinuation syndrome, and other serious side effects.

Paxil: Research Studies and FDA Warnings

Paxil has been embroiled in controversies regarding its efficacy and side effects since its market availability. In June 2003, the FDA warned against sudden discontinuation of the drug by children and teenagers, saying that severe withdrawal symptoms could be fatal for them. A similar advisory issued by the European Medicines Agency in December 2004, advised against prescribing Paxil to children. It also recommended close observation of adult patients taking the drug for the risk of suicidal behavior.

In March 2005, the FDA seized Paxil tablets from different U.S. locations citing that the manufacturing practices were not in accordance with federal standards on safety, quality, efficacy, and purity. In December 2005, the FDA updated label warnings on the drug and alerted patients and health care professionals to possible heart defects in newborns caused by administration of Paxil therapy to pregnant mothers during the first three months. This was supported by statistics and documents released by Swedish Medical Birth Register in 2010 on infant cardiovascular defects caused by antidepressants.

A FDA health advisory issued in May 2006 warned about the risk of suicidal attempts by young adults treated with Paxil. A study funded by Paxil manufacture GlaxoSmithKline and published in the April 2011 issue of the Journal of Clinical Psychiatry warned that

Vaginal Mesh Implant Lawsuit

2011-07-28T22:04:48+00:00

Vaginal Mesh Implant Lawsuit

If you have received a transvaginal mesh implant, you might be at risk.

The Food and Drug Administration, FDA, has issued a warning regarding the risks involved in using surgical mesh implants, which are used to treat cases of pelvic organ prolapse. About 1,503 adverse event cases related to the vaginal placement of mesh have been reported to the FDA between 2008 and 2010. The FDA warning says that the risks outweigh the benefits of mesh implants, which are permanently implanted vaginally or abdominally to reinforce the vaginal tissue or wall.

The FDA review, carried out from 1996 to 2010, found that mesh implants used in transvaginal pelvic organ prolapsed repair posed a greater risk of pain, bleeding, and infection to the patient. Besides, women with such implants might even be forced to undergo additional surgeries or hospitalization.

Studies comparing mesh surgeries to non-mesh surgeries conducted between 1996 and 2010 have found that the number of adverse events has been constantly rising. Following the review, the FDA suggested that many patients having undergone transvaginal mesh implant surgery were exposed to additional risks compared to patients opting for POP repair with stitches. The first safety warning about the mesh implants came up in 2008 following increasing concerns about adverse events.

The federal body has received numerous complaints of adverse events associated with mesh implants, which include pain, bleeding, infection, erosion through the vaginal tissue, pain during sexual intercourse, urinary problems, and organ perforation from surgical equipment.

The latest FDA warning says patients undergoing surgery for pelvic organ prolapse are at a greater risk than other surgical procedures. Further, the FDA has not found any improvement in the quality of life of patients who had undergone implantation of surgical mesh.

Patients have complained that they experience sparking constant pain around the area and have to undergo a number of surgeries to remove the mesh that eroded in their vagina. The FDA has not ruled out “serious complications” in some cases. According to the federal agency, nearly half of all women

Avonex Lawsuit Attorney

2011-07-25T08:22:16+00:00

Avonex Lawsuit Attorney

Avonex Side Effects Lawsuit

Avonex, manufactured by Biogen Idec, is used for multiple sclerosis treatment. The drug is developed form beta interferon protein and prescribed worldwide to treat relapsing form of multiple sclerosis. Administered as a muscle injection, Avonex helps relieve a number of multiple sclerosis symptoms. It strengthens the immune system and helps fight viral infections, which slows down progression to physical disability and reduces the incidence of relapses that impact the central nervous system.

The FDA approved Avonex in 1996 as a drug for treating relapsing multiple sclerosis forms. In 2003, it was allowed to be administered to patients diagnosed with relapsing multiple sclerosis attack through brain MRI scans. With over $1 billion in annual sales, the drug therapy has been used by more than 130,000 patients in 90 countries. However, Avonex has been linked to nervous system breakdown and serious hepatic, cardiovascular, and hematologic side effects. It causes liver disease, severe depression, heart problems, and seizures in patients.

Avonex Lawsuit Warnings by FDA

In May 2001, the FDA warned Biogen against violating federal advertising rules and ordered for immediate halting of misleading promotions of its multiple sclerosis drug Avonex. The manufacturer tried to promote Avonex use for secondary multiple sclerosis treatment, which is not approved by the federal regulator.

In March 2005, the FDA issued a public advisory warning patients and health professionals about possible liver failure in certain conditions caused by Avonex. Just a fortnight before the warning, the regulator had suspended sale of Tysabri, a multiple sclerosis drug by the same manufacturer, for causing fatal

ProHance Side Effects Lawsuit

2011-07-24T07:16:54+00:00

ProHance Side Effects Lawsuit

ProHance, brand name of Gadoteridol, is a popular gadolinium-based contrast agent manufactured by pharmaceuticals major Bracco Diagnostic. The contrast drug helps in improved MRI of the central nervous system. ProHance also helps radiologists easily distinguish leaky blood vessels and problematic tissues in patients during MRI scans. However, the side effects of the drug can lead to rare disorders, such as Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy, in people with impaired renal function. It has also been linked to liver problems, cardiovascular side effects, skin diseases, and other potentially life-threatening conditions.

ProHance and FDA Warnings

The FDA approved ProHance in 1999 for clinical use. Following numerous reports of epidermal and dermal side effects, the FDA issued a public health advisory in June 2006, informing health professionals about possible fatal skin disorders caused by the drug. A study by the Danish Health Authority in 2007 highlighted 25 Nephrogenic Systemic Fibrosis cases, where patients with impaired kidney and liver functions developed the rare disorder after taking gadolinium-based contrast injections during diagnostic tests.

The findings of the Danish report prompted the FDA to

Avandamet Side Effects Lawsuit

2011-07-15T02:53:45+00:00

Avandamet Side Effects Lawsuit

Avandamet, comprising rosiglitazone and metformin, is a commonly prescribed drug for Type 2 diabetes patients. Approved in 1999, Avandamet works by reducing the amount of sugar produced by the liver, thus making the body more sensitive to the naturally produced insulin. However, avandamet is often linked to heart attacks, primarily because of the presence of Avandia or rosiglitazone. Manufacturer GlaxoSmithKline faces numerous lawsuits, linking the drug to severe side effects.

FDA and Avandamet

In 2010, the Federal Drug Administration first reported the possible risk of cardiovascular events on patients using rosiglitazone and thus restricted its use, allowing only those individuals to continue using the drug who do not respond to other diabetes medications.

Earlier, in 2005, the FDA seized the current Avandamet stock, thus removing the drug from the market, after its inspection team reported violation of good manufacturing norms at a GlaxoSmithKline factory. The FDA inspection team found that some Avandamet tablets had lower than the average dose of rosiglitazone, which might have resulted in poor quality drug products, causing health complications for some patients. Following this, GlaxoSmithKline only recalled some of the affected lots of Avandamet. This prompted the FDA to interfere, which

Neurontin Side Effects and Lawsuit

2011-07-15T02:48:18+00:00

Neurontin Side Effects and Lawsuit

Pfizer’s Neurontin, brand name of gabapentin, is one of the best selling anti-epileptic drugs. Approved by the FDA in 1983, the medication is used to treat seizures caused by epilepsy and neuropathic pain. Neurontin is also administered during the expensive Prometa Treatment Protocol for addiction rehabilitation. The drug has been linked to serious nervous system problems and psychiatrist disorders, including cases of suicides. Manufacturer Pfizer faces numerous lawsuits for marketing the drug for a dozen uses not approved by the FDA.

Neurontin Warnings and Complaints

In 2008, the FDA asked Pfizer to put label warnings highlighting risk of suicidal thoughts on Neurontin. In 2009, the federal regulator updated the warning stating that the drug significantly increased the risk of depression, suicide, and behavioral changes. In April 2010, an epilepsy drug research study published in the Journal of the American Medical Association, warned against off-label use of the drug for migraine, bipolar disorder, and depression. According to the report, the drug increases suicidal risk in such conditions that have already made patients prone to these kinds of thoughts.

An investigating report published in the Archives of Internal Medicine in June 2011 has alleged that Pfizer deceived doctors and patients on the safety and effectiveness of Neurontin. According to it, the original motive of the manufacturer in recruiting doctors for anti-epilepsy medication study was to increase the prescription of the drug.

Metoclopramide Side Effects Lawsuit

2011-07-15T02:31:32+00:00

Metoclopramide Side Effects Lawsuit

Metoclopramide, generic name of Reglan, is an antiemetic medication that offers short-term relief from heart burn and vomiting caused by gastroesophageal reflux. It speeds up stomach muscle functions that help in quick digestion of food. However, metoclopramide side effects lead to drug-induced movement disorders, nervous system breakdowns, and numerous major health problems. The drug has been linked to tardive dyskinesia, a serious and irreversible movement disorder.

Metoclopramide FDA Warning

The FDA allows metoclopramide drugs only as a short-term measure – up to 12 weeks. It has notified both doctors and consumers about the serious side effects of the drug associated with the off-label use. In February 2009, the FDA issued a public health advisory alerting healthcare professionals in the United States to the possible link between metoclopramide and tardive dyskinesia. It added a black box warning to the drug informing consumers and doctors about the possible side effects due to long-term use and overdose of the drug. The new label changes were made mandatory for both metoclopramide tablets and injections. The FDA also asked the manufacturer of these drugs to make necessary arrangements to put in place a proper risk evaluation and mitigation strategy so that patients receiving their drugs would be fully informed about the risk associated with metoclopramide side effects.

Metoclopramide Side Effects

Tardive Dyskinesia

Metoclopramide can cause tardive dyskinesia, a rare and fatal movement disorder. The risk of this irreversible disorder is proportionate to the duration of the drug therapy and the total cumulative dose. The longer is the duration, the greater is the risk. This neurological disorder leads to involuntary and repetitive movements of upper limbs and the lower face. Lip smacking, pursing one’s lip, chewing, impaired finger movements, unexplained and uncontrolled grimacing, troubled respiration, and brisk eye movements are the common symptoms of this syndrome. These conditions induced

Fosamax Side Effects Lawsuit

2011-07-15T01:04:54+00:00

Fosamax Side Effects Lawsuit

Alendronic acid or Alendronate, sold as Fosamax by Merck, was licensed in 1995 as a treatment for osteoporosis. Since 1995, more than 10 million patients have taken the drug. The bisphosphonate drug is mostly sold as a treatment for bone diseases, where there is a loss of bone mass. Fosamax is designed for the treatment of bone loss due to advanced cancer, Paget’s disease, or post-menopausal osteoporosis.

FDA Warning on Fosamax

In 2004, the Food and Drug Administration asked Merck & Co. to issue a warning about the Fosamax side effects; however, a number of patients allege the drug manufacturer never informed them that the bisphosphonate drug posed a risk of jaw necrosis. About 3,000 cases of jaw necrosis have been reported among bisphosphonate drug users, including Fosamax, since 2003. In 2010, the FDA issued another warning for Fosamax consumers that they were at the risk of thigh fracture following long-term use of the drug.

Fosamax Lawsuit

Merck faces more than 900 Lawsuit nationwide over the side effects of Fosamax. In a recent lawsuit, in 2010, a federal district judge in Manhattan refused to dismiss a Fosamax lawsuit against defendant Merck & Co Inc's. The plaintiff from Indiana, Louise Maley, had alleged that after having taken Fosamax for eight-long years, she suffered jaw damage.

Fosamax Side Effects

Though Fosamax effectively works to prevent bone loss, serious side effects have been reported as a result of the use of the drug.

Omniscan Side Effects Lawsuit

2011-07-15T00:15:39+00:00

Omniscan Side Effects Lawsuit

Omniscan, manufactured by GE Healthcare, is a gadolinium-based intravenous contrast agent used during diagnostic tests to visualize lesions causing abnormal vascularity in the brain, blood vessels, spine, and other non-bony tissues in the body. However, the drug causes development of Nephrogenic Systemic Fibrosis (NSF), a rare and fatal syndrome in patients suffering from moderate to end-stage renal insufficiency.

Omniscan Warnings and Reports

A public health advisory issued by the FDA in December 2006 warned patients suffering from kidney diseases that Omniscan and other gadolinium-based contrasting agents posed heath risks. It disclosed that 90 kidney patients in the United States using Omniscan were diagnosed with Nephrogenic Systemic Fibrosis. Research reports confirmed that gadolinium-based contrast agents, such as Omniscan, were responsible for the disorder in at least 75 of the 215 Nephrogenic Systemic Fibrosis cases reported worldwide. In 2007, the FDA ordered label changes on Omniscan and asked manufacturer to include “black box” warning on the package highlighting severe side effects for kidney patients.

In February 2008, Danish media and drug regulator extensively reported on the side effects of Omniscan, Bayer AG's Magnevist, and three other gadolinium-based agents. While the media claimed 60 persons had died or were severely disabled due to a rare toxic reaction caused by the drug, the Danish Medicines Agency confirmed 35 cases of Nephrogenic Systemic Fibrosis syndrome linked to Omniscan.

Omniscan has also been linked to acute renal failure. A study published in 2001 reported three cases of renal toxicity and pancreatitis in patients who had taken Omniscan during diagnostic tests. Numerous cases of Nephrogenic Systemic Fibrosis syndrome, renal impairment, restrictive pulmonary disease, septic shock, skin disorder, and other Omniscan side effects were reported in Japan, the United Kingdom, Taiwan, Netherlands, the United States, Denmark, and France between September 2007 and April 2008.

In September 2010, the FDA placed specific limitations on the use of Omniscan Contrasts Dye following expert panel recommendations on its side effects. The label changes on the drug require doctors to screen patients for kidney dysfunction before administering the contrast agent. According to medical journal Radiology,

Optimark Side Effects Lawsuit

2011-07-15T00:01:58+00:00

Optimark Side Effects Lawsuit

Tyco Healthcare’s Optimark is one of the five gadolinium-based contrast agents approved by the FDA for contrast enhancement during MRI scans of the brain, spine, and liver. The drug administered by intravenous injections facilitates visualization of lesions responsible for abnormal vascularity in patients. The drug has been linked to a fatal risk for those with impaired renal function. According to research reports and post-marketing survey, gadolinium-based contrast agents put kidney patients at the risk of Nephrogenic Systemic Fibrosis (NSF), a progressive disorder that results in limited mobility and death.

Optimark Warnings

The FDA approved Optimark in December 1999. The drug was advertised as an alternative to Bayer AG's Magnevist and GE Healthcare’s Omniscan, two well-known MRI contrast agents in the market. However, the FDA issued a public advisory in June 2006 informing patients and medical practitioners about Optimark side effects on kidney patients following reports of fatal Nephrogenic Systemic Fibrosis associated with gadolinium-based contrast agents.

In May 2007, the FDA ordered for "Black Box" warning on four gadolinium-based contrast drugs, including Optimar, following a staff review. The changed labels alerted patients with chronic renal insufficiency and liver problems about fatal side effects of the drug. The federal regulator cited 35 cases of fatal skin diseases in patients who took the drug. In November 2009, the federal regulator named Optimax among the top three gadolinium-based contrast agents associated with the highest risk of Nephrogenic Systemic Fibrosis skin disorder. In December 2009, a panel of experts appointed by the FDA called for tighter restrictions on Optimark. The FDA issued a drug safety communication on September 9, 2010

Nuvaring Side Effects Lawsuit

2011-07-12T08:53:41+00:00

Nuvaring Side Effects Lawsuit

NuvaRing, a composition of ethinyl estradiol and etonogestrel, is a contraceptive vaginal ring available on prescription. The flexible plastic contraceptive ring, manufactured by Merck & Co, Organon BioSciences, and Schering-Plough, releases a low dose of progestin and estrogen hormones over a period of three weeks. The FDA approved NuvaRing on October 3, 2001, and over 1.5 million women worldwide use the contraceptive ring. However, two studies link NuvaRing with serious device-related side effects. More than 15.1 percent of the users have discontinued the use of the device after experiencing sexual problems, foreign object sensation, and expulsion.

NuvaRing Lawsuit

More than 730 personal injury and wrongful death Lawsuit have been filed against the manufacturer and marketer of NuvaRing for failing to warn consumers about the health risks associated with NuvaRing, including possible blood clot complications and related injuries, such as deep vein thrombosis, pulmonary embolism, heart attacks and strokes.

In March 2008, a lawsuit was filed against Merck for not disclosing health risks associated with the device usage. The lawsuit claims that the use of NuvaRing had caused death of the plaintiff's wife. While Merck continues to deny the allegations, trials for many Lawsuit are scheduled for 2012. Many Lawsuit find major problems with the advertising of NuvaRing, which downplays the threat of risks associated with the device.

Mesh Lawsuit Settlement

2011-07-07T02:15:16+00:00

Mesh Lawsuit Settlement

C.R Bard has agreed to a settlement amount of $184 million dollars to settle the majority of kugel mesh lawsuits filed against the company as a result of faulty surgical mesh products manufactured by its subsidiary Davol Inc., makers of the Kugel mesh.

The multi-million dollar settlement reached in federal court and disclosed in Bard's second quarter filing will be allocated for and distributed to roughly 2,600 patients who were injured by the companies Davol mesh products including the Kugel mesh.

For more information please contact the lead attorney handling defective mesh lawsuits by submitting your case here or calling the firm directly at 1-800-748-7115

Zyprexa Lawsuit

2011-07-06T09:31:59+00:00

Zyprexa Lawsuit

Zyprexa Side Effects Lawsuit

Zyprexa by Indiana-based pharma major Eli Lilly is atypical antipsychotic medication useful for the treatment of psychotic conditions, including schizophrenia and bipolar disorder. Approved in 1996, the drug raked $5 billion in annual sales last year. However, Zyprexa has been linked to diabetes, disorders caused by nervous system breakdown, and metabolic disorders in patients. The drug is also harmful for fetus and may cause defective birth – infants born with nervous system and respiratory disorders.

Zyprexa Complaints and Warnings

The FDA has received around 400 reports of diabetes caused by Zyprexa use. The British and Japanese national drug regulators have also identified serious hyperglycemia and diabetes cases caused by the drug. In November 2001, an article in the Journal of the American Medical Association was the first to report the possible association between the drug and hyperglycemia in adolescents. The FDA staff review in December 2001 also echoed the same apprehensions.

A study conducted by Duke University Medical Center in 2002 reported that patients taking Zyprexa are susceptible to ketoacidosis, a serious complication induced by diabetes. The research identified 300 Zyprexa-linked diabetes cases, including 100 patients with ketoacidosis, 22 with fatal pancreatitis, and 20 deaths caused by Zyprexa side effects. The British Medical Journal also reported extensively on the diabetes risk to schizophrenia patients taking Zyprexa.

The Japanese Ministry for Health and Welfare and the nodal medicine control agency in the United Kingdom immediately issued warnings highlighting diabetes-related complications from the drug. The British National Formulary also recommended gradual recall of the drug citing acute withdrawal syndrome associated with it.

In 2003, the FDA asked manufacturer Eli Lilly to strengthen the label warnings on Zyprexa. The new product information alerted consumers and doctors of diabetes related potentially fatal side effects. In 2004, the U.K. Committee on the Safety of Medicines called for restrictions on prescribing Zyprexa to elderly patients with dementia. In December 2006, a report in New York Times claimed Eli Lilly made subtle attempts to play down reports on the health risks of Zyprexa. It cited several internal communications in the company on the possible diabetes side effects observed during the trial but never published or reported to the FDA.

Zyprexa Side Effects

Diabetes and Metabolic Side Effects:

Zyprexa carries a greater risk of inducing and aggravating diabetes compared to other antipsychotic medication. It affects the metabolic process, promotes fat deposition, decreases insulin sensitivity, and increases triglyceride levels. The drug makes our body obtain energy from fat. As a result, carbohydrates remain unutilized in the body. This leads to development of insulin resistance. The drug also increases appetite leading to binge eating, weight gain, acidosis, hypoglycemia, hypokalemia, and hyponatremia. Diabetes patients are at the risk of ketoacidosis accumulation of glucose and carbohydrates in the body

Nervous System Problems:

Zyprexa overdose causes somnolence and neuroleptic malignant syndrome. The disorder, which causes autonomic dysfunction, muscle rigidity, and altered cognitive performance, has above 20 percent mortality rate. The drug also develops sleep-related eating disorder, acute withdrawal symptoms, insomnia, hypertonia, emotional lability, agitation, and facial paralysis.

Cardiovascular Side Effects:

The common side effects include

tachycardia and hypertension. The post-marketing studies have reported congestive heart failure, hemorrhage, atrial fibrillation, cerebrovascular accident, and pulmonary embolus linked to the drug. Elderly patients with dementia are at greater risk of death due to heart failure caused by Zyprexa.

Gastrointestinal Side Effects:

Zyprexa leads to flatulence, increased appetite, frequent dry mouth, constipation, and increased salivation. Other side effects, such as dysphagia, gastroenteritis, mouth ulceration, periodontal abscess, and rectal hemorrhage, have also been reported. The FDA has also received a few complaints of Zyprexa -induced acute pancreatitis.

Hepatic Side Effects:

A 78 year-old woman, who had no prior lever problem, reportedly developed severe hepatic side effects within 13 days of taking Zyprexa. The drug has also been linked to rare side effects, such as hepatitis, mixed liver injury, and liver fatty deposit.

Respiratory Side Effects:

Zyprexa infection causes pneumonia and other fatal respiratory problems in elderly patients. Asthma, apnea, increased cough, dyspnea, hypoxia, voice alterations, lung edema, and fatal lower respiratory tract infection have also been reported.

Other Zyprexa Side Effects:

Ocular problems attributed to Zyprexa include amblyopia, abnormal vision, cataract, eye hemorrhage, and ocular muscle abnormality. The drug can lead to hematologic disorders, resulting in anemia, leukocytosis, leukopenia, and thrombocythemia. Zyprexa musculoskeletal side effects include extremity pain, arthritis, and osteoporosis.

Zyprexa Lawsuit

Eli Lilly faced the first Zyprexa class action lawsuit in 2004, seeking compensation for all those who had suffered from the side effects of the drug. In September 2008, a New York federal judge allowed another class action to proceed. The plaintiffs, third party payors, accused the manufacturer of selling the drug at high prices, overstating its benefits, and hiding the Zyprexa side effects. In November, an Ontario court certified another Canadian class action seeking recovery of the money the consumers had paid for the drug purchase. It cited the sufferings the consumers had undergone due to failure of Eli Lilly to inform about the drug side effects.

In 2005, Lilly announced that it would set up a $700 million fund to settle 18,000 personal injury Lawsuit. In 2007, it paid $500 million to 12,000 plaintiffs, who claimed to have developed diabetes after taking Zyprexa. There are still 1,200 Lawsuit awaiting trial or settlement in the United States. The Canadian class action is to cost a whopping $900 million to the pharma major. In 2009, Eli Lilly was fined $1.4 billion for illegally marketing and promoting off-label use of Zyprexa.

Ortho Evra Lawsuit

2011-07-06T09:25:25+00:00

Ortho Evra Lawsuit

Ortho Evra Side Effects Lawsuit

Ortho Evra contraceptive skin patch by Johnson & Johnson’s subsidiary Ortho-McNeil has been popular since November 2001. The patch contains a combination of hormones that prevents ovulation in females. It also causes changes in cervical mucus, which, in turn, prevents sperms from reaching the uterus. However, Ortho Evra has serious side effects. According to an Associated Press investigation report, the hormonal contraception patch triples the risk of developing life-threatening blood clots. The serious side effects of the drug include deep vein thrombosis, strokes, pulmonary embolisms, heart attacks, and deaths.

Ortho Evra Complaints and Warnings

According to a study conducted by the FDA in 2004, Ortho Evra led to a three-fold increase in blood clot-related fatal incidents, such as pulmonary embolisms, strokes, heart attacks, and deaths. The reports, made public by the Associated Press in July 2005, claimed that there were at least 23 Ortho Evra deaths, including 17 caused by blood clots until 2004. The study was also apprehensive that the actual side effects were more widespread as the post-marketing reviews covered only 1-10 percent patch users.

The first known Ortho Evra fatality was reported in April 2004. Autopsy of an 18-year-old Manhattan fashion student revealed a blood clot in the lung. The victim was using Ortho Evra and the medical examiner blamed the side effects of the birth control patch for the young woman's death. Another woman, a 25 year-old-mother of three, died of blood clots in her brain. The medical reports held hormones released by Ortho Evra responsible for the death.

In November 2005, the FDA ordered the manufacturer to modify labels on the drug reflecting the increased risk of blood clots and other severe side effects. An advisory issued by Ortho McNeil within days warned that the patch exposed users to 60% more estrogen than pills, which could lead to serious health risks. In March 2006, the FDA announced further review of Ortho Evra and asked label update on the package following a comparative study on the side effects of the patch and other birth control pills. According to the research, the excessive hormones in the patch do not dilute during the digestive process, unlike other pills. They are absorbed directly into the blood stream and cause higher concentration of estrogen, which puts users at a greater risk of clots, thrombosis, and heart strokes.

The consumer advocacy group Public Citizen filed a petition signed by 80,000 individuals to FDA demanding recall of Ortho Evra in May 2008. The petition mentioned cases of unreasonable blood clot and other serious health problems that the birth control patch caused within six months of taking it.

Ortho Evra Side Effects

Blood Clots:

Thromboembolic risks are the most documented side effect of Ortho Evra. The patch increases level of estrogen and progestin hormones in the blood. It releases 60 percent more estrogen compared to birth control pills, and this directly enters the patient’s blood stream, putting them at a greater risk of developing blood clots. Most of the Ortho Evra side effect victims are diagnosed with deep vein thrombosis and pulmonary embolism. Blood clots mostly develop in a deep vein in the pelvic region or legs. It breaks off and travels upward to the lungs, which can cause major artery blocks.

Bextra Lawsuit Attorney

2011-07-06T09:18:07+00:00

Bextra Lawsuit Attorney

Pfizer withdrew Bextra from the U.S. market in April 2005 on the recommendation of the FDA. Introduced in November 2001, this non-steroidal anti-inflammatory drug was used to treat pain, stiffness, and inflammation associated with arthritis and other ailments. However, a number of research reports and government reviews held the drug responsible for causing rare skin reactions and increased risk of fatal cardiovascular problems in users.

Bextra Complaints

Bextra was the second Cox-2 inhibitor to be withdrawn from the market after the Vioxx recall in 2004. Some of the side effects of the drug includes increased risk of heart attack, stroke, rare skin disease called Stevens–Johnson syndrome.

In October 2004, Pfizer acknowledged the cardiovascular side effects of Bextra. A report presented to the American Heart Association also highlighted that patients using Bextra were 2.19 fold more likely to suffer heart attack or stroke. A study published by the University of Pennsylvania in November claimed that Bextra posed greater risk of heart attack and stroke than Vioxx, which was withdrawn a month before the report had been made public.

In December 2004, the FDA issued a public health advisory asking doctors to limit use of Bextra and diagnose heart patients properly before prescribing the drug. Four months later, the federal regulator ordered Pfizer to immediately stop selling Bextra, citing major heart and skin problems caused by the drug. The European Union and Canada also suspended the sale of the drug with immediate effect. In December 2005, Health Canada banned Bextra on the recommendations of an expert panel.

In March 2009, a former sales manager from Boston pleaded guilty to selling Bextra inappropriately. She had directed 100 sales representatives working under her supervision to promote the drug for reasons rejected by the FDA. About half a dozen whistleblowers followed the suit and disclosed the unlawful practices adopted by Pfizer for marketing Bextra to the federal investigators.

Bextra Side Effects

Skin Disorders

The FDA has received reports of 87 cases of severe skin reactions, including four deaths, linked to Bextra. Stevens-Johnson Syndrome, a toxic epidermal necrolysis disorder, is the most prominent side effect of the drug. Many patients found themselves affected with the syndrome within two weeks of taking the drug. This complex syndrome affects the skin and mucous membranes, leading to rashes, mucosal lesions, and cell death.

Cardiovascular Side Effects

Magnevist Side Effects Lawsuit Attorney

2011-06-29T10:15:32+00:00

Magnevist Side Effects Lawsuit Attorney

Bayer’s Magnevist was the first intravenous contrast drug to be approved for clinical use in the United States in 1988. The drug helps make diagnostic tests, such as MRI scans, easier to read. It is administered to patients before they take diagnostic tests to ensure a clear view of leaky blood vessels, organs, and various non-bony tissues in the body. However, patients taking the drug have suffered from several disabling and potentially life-threatening conditions, including liver problems, fatal skin diseases, and Nephrogenic Systemic Fibrosis (NSF) – a rare kidney disease.

Topamax Birth Defects Lawsuit

FDA Warning on Magnevist Side Effects

In June 2006, the FDA first alerted medical practitioners about fatal Magnevist side effects following the identification of 25 Nephrogenic Systemic Fibrosis cases by the Danish Health Authority. A public health advisory by the federal regulator warned about the risk of fatal skin diseases and NFS disorder in kidney and liver patients using gadolinium-based imaging agents, including Magnevist. The drug triggers thickening of the skin, tissues, and organs, causing difficulty in movement and broken bones. In May 2007, the FDA asked the drug manufacturer to add mandatory "Black Box" labels on the drug, alerting patients with kidney and liver problems about possible side effects.

Aredia Side Effects Lawsuit Attorney

2011-06-25T21:52:38+00:00

Aredia Side Effects Lawsuit Attorney

A research report published in the Journal of the American Medical Association has advised patients to closely weigh benefits and risks of Osteoporosis drug Aredia and consult with their physicians before using the potentially harmful drug.. According to the study, long-term use of bisphosphonates, such as Aredia, can lead to increased risk of atypical fractures in older women and also cause fractures in the femoral shaft. Aredia Side Effects Lawsuit Attorney

Aredia, brand name of the drug Pamidronate, was approved by the FDA in 1994 as a treatment for bone loss in cancer patients. It controls calcium levels in the blood and secures the bones and blood stream against the effects of cancer. It is also helpful in treating patients suffering from Paget’s disease, bone tumors, and brittle bone disorder. It is estimated that over 36 million women use Aredia to slow down osteoporosis. However, numerous reports in the recent years have linked the drug to a number of health complications, such as Osteonecrosis of the jaw, deterioration of renal function, kidney failure, and unexplained musculoskeletal pain.

FDA Warning

In September 2004, the FDA issued a health advisory, warning doctors against prescribing Aredia to patients with a history of dental problems. The regulatory agency specifically mentioned Osteonecrosis of the Jaw as a side effect of the drug. In January 2008, the FDA issued another public health advisory, warning that the drug could lead to severe and debilitating pain in muscles, back, joints, and bones. Aredia Side Effects Lawsuit Attorney

Aredia Complaints

Numerous reports from Germany, England, Japan, and the United States have documented reported complaints of Aredia side effects, such as calcinosis, pneumonia, and periodontitis. In June 2005, an 81-year-old U.S. patient suffering from multiple myeloma was diagnosed with Osteonecrosis of the jaw, aseptic necrosis bone, and periodontitis. Her problems were blamed on Aredia. The same problem was reported in a German female patient and a French resident in January 2007 and five Japanese patients between May and November 2007. All the patients started taking Aredia after being diagnosed with bone metastases.

According to reports published in September 2006, two patients in the United Kingdom developed nephrotic syndrome, pneumonia, and renal failure one year after taking Aredia regularly for bone metastases. Both patients died subsequently. Aredia Side Effects Lawsuit Attorney In the United States, eight such cases of patients suffering from Osteoporosis, multiple myeloma, and narcolepsy were reported between April and October 2007. However, some of them recovered after the administration of Aredia was stopped.

Reports from Germany and the United States between January 2007 and December 2008 highlighted at least 10 cases of Aredia side effects, including calcinosis, bone disorder, actinomycosis, aortic valve incompetence, bone debridement, and dental caries.

Recent Aredia Research Reports

According to a report in the International Journal of Oral and Maxillofacial Surgery, patients taking Aredia and other bisphosphonates are four times more likely to develop Osteonecrosis of the Jaw. Another report published in the last week of May 2011 claims that Aredia only reduces skeletal-related problems in patients suffering from suppressed multiple myeloma but does not prevent progression of the disease. An article in the October 2010 issue of The Lancet Oncology cited clinical results to prove that increase in the Aredia dose did not provide any extra benefit to multiple myeloma patients.

Aredia Side Effects Lawsuit

Aredia Side Effects Lawsuit Osteonecrosis of the Jaw:

Aredia causes jaw bone necrosis. Its symptoms are jaw pain, falling teeth, swollen gums, and bone problems in the oral cavity. Patients may need to have dead bones in specific parts of the jaw removed. There have been numerous reports of patients suffering from Osteonecrosis of the Jaw and other periodontal side effects of Aredia in the United States, Europe, Japan, and India.

Aredia Side Effects Lawsuit Renal disorientation and kidney problem:

Aredia has been linked to renal toxicity that causes deterioration of renal function and kidney failure. According to the postmarketing data, patients using the drug have developed focal segmental glomerulosclerosis and nephrotic syndrome. Such conditions can lead to decreased kidney function and presence of blood and protein in urine.

Aredia Side Effects Lawsuit Cardiovascular problems:

Aredia side effects can cause rare atrial fibrillation, leading to erratic heartbeat and even death. A number of patients taking Aredia have been hospitalized for treatment of fluid overload, tachycardia, hypertension, and cardiac failure.

Aredia Side Effects Lawsuit Musculoskeletal side effects:

According to a public health advisory issued by the FDA, osteoporosis drugs, including Aredia, cause sudden debilitating musculoskeletal pain. Patients may experience severe

Zometa Side Effects Lawsuit Attorney

2011-06-22T23:13:38+00:00

Zometa Side Effects Lawsuit Attorney

According to a study published in the June 2011 issue of the Journal of Supportive Oncology, administration of Zometa intravenously over a long period can lead to kidney damage. Zometa marketed by Novartis is a bisphosphonate drug used to treat high level of calcium in the blood and prevent skeletal fractures in cancer patients. It is prescribed to patients suffering from multiple myeloma or bone marrow cancer, prostate cancer, osteoporosis, hypocalcaemia of malignancy, and pain caused by bone metastases. However, the drug may lead to development of bone necrosis in the jaw, known as osteonecrosis and several other health problems in patients. The drug activates gamma/delta T cells in the human body leading to flu-like symptoms and hypersensitivity. Zometa is also linked to renal problems and kidney failure in users.

Zometa Lawsuits and Complaints

The FDA approved Zometa in February 2002 to treat multiple myeloma and documented bone metastases in cancer patients. A study published in the Journal of Oral and Maxillofacial Surgeons in September 2004 disclosed a link between the drug and osteonecrosis of the jaw, a serious bone disease. It prompted both the FDA and manufacturer Novartis to issue public health advisory warnings informing health care professionals about the possible side effects of the drug and urging them to limit its use in specific cases. The FDA asked the doctors to make proper dental examination of patients before prescribing the drug.

In 2006, a Rhode Island widow filed a lawsuit against Novartis claiming that the delay by the pharma major in informing Zometa side effects was the cause behind the suffering of her husband. Timothy Hogan, who died of cancer in 2005, suffered from osteonecrosis of the jaw after using the drug between 2003 and 2005. In October 2009, a Missoula County District Court awarded $3.2 million to a Montana woman, who developed debilitating jaw problems after using the drug for three years to treat lymphoma. She had accused Novartis of failing to adequately warn about possibility of jaw necrosis in users.

In May 2010, a New Jersey federal judge cleared the way for trial in 150 Zometa lawsuits filed against Novartis in the state and 40 lawsuits in Florida. In November 2010, the court ordered Novartis to pay $12.8 million as compensation to the family of Rita Fussman, a North Carolina woman. The deceased’s family had alleged that she had suffered before her death on account of jaw bone problem caused by the drug. About 550 Zometa lawsuits have been consolidated under multidistrict litigation and the U.S. District Court in Nashville, Tennessee, is designated to try them.

Various reports presented in annual conference of the American College of Chest Physicians since 2008 have highlighted the cardiovascular risks associated with the drug. Several comparative studies have also reported that the health risks associated with Zometa are much higher than other drugs of its class.

Zometa Side Effects Lawsuit Attorney

Osteonecrosis of the Jaw

The most serious side effect of Zometa is jaw bone necrosis. It causes jaw pain, loosening of the teeth, swelling or infection of the gums, feeling of heaviness in the jaw, and exposed bone in the oral cavity. More than 90 percent of complaints reported in Zometa lawsuits are on osteonecrosis of the jaw and related suffering.

Metabolic problems

A large number of patients using Zometa during cancer treatment suffered from metabolic side effects of the drug, such as hypomagnesaemia, hypokalemia, hypophosphatemia, and hypocalcaemia. These disorders can cause kidney problems, heart abnormalities, and adrenal tumors.

Renal side effects

Zometa side effects can lead to renal problems. Kidneys process Zoledronate in the drug rapidly which can cause reduced renal function and kidney disease. Several patients have complained about renal toxicity, urinary tract disease, blood in urine, proteinuria, and hypernatremia after using the drug for long time.

Hematologic impacts

Zometa can cause anemia and neutropenia. Around 30% of patients found to have anemia after using the drug during a clinical study. Granulocytopenia, thrombocytopenia, and pancytopenia may also occur in patients using the drug.

Trasylol Side Effects Lawsuit Attorney

2011-06-22T22:57:42+00:00

Trasylol Side Effects Lawsuit Attorney

Bayer pharmaceuticals withdrew its anti-bleeding drug Trasylol in May 2008 in the face of an avalanche of complaints and lawsuits. Known by its generic name aprotinin, the drug was administered by injections to stop bleeding during complex surgeries. It is known to slow down the process of blood clotting and minimize the need for blood transfusion during major heart surgeries and liver transplantation. However, the rising number of complaints linking Trasylol to death and risks of other complications forced the FDA to suspend the drug sales in November 2007 and order its complete removal six months later.

Complaints Against Trasylol Side Effects Lawsuit

The FDA approved Trasylol in December 1993. During its 14-year market presence, the drug was embroiled in several controversies. The FDA accused manufacturer Bayer of

Trasylol Lawsuit Attorney

2011-06-21T22:52:49+00:00

Trasylol Lawsuit Attorney

Trasylol Side Effects Lawsuit

Trasylol Side Effects

Bayer pharmaceuticals withdrew its anti-bleeding drug Trasylol in May 2008 following numerous complaints and lawsuits on its side effects. A brand name of the drug aprotinin, Trasylol was administered by injections to stop bleeding during complex surgeries. The drug slows down the process of blood clotting and minimizes the need for blood transfusion during major heart surgeries and liver transplantation. The FDA suspended Trasylol sales in November 2007 and ordered its complete removal six months later after it received numerous complaints linking the drug to death and other serious complications.

Trasylol Complaints

The FDA approved Trasylol in December 1993. During its 14-year market presence, the drug had been embroiled in controversies. The FDA accused manufacturer Bayer of hiding information on drug safety while research and media reports held the drug responsible for thousands of kidney failure cases and deaths caused by renal failure and heart strokes. About 22,000 people died in the United States between January 2006 and November 2007 due to the side effects of the drug.

In 2006, a research report by the Ischemia Research and Education Foundation, California, on cardiac surgery patients put spotlight on the serious side effects of Trasylol. The findings showed that the overactive inhibition of the fibrinolysis caused by the drug could lead to acute renal and heart failure, myocardial infarction, stroke, and encephalopathy in users. An updated report by the same institution in 2007 presented more evidences on Trasylol side effects.

In September 2006, the FDA accused Bayer of withholding safety information obtained during commissioned Trasylol studies. It ordered for labeling revisions to reinforce safety warnings and limit the drug use to specific situations following the review of Trasylol postmarketing database. In October 2006, the federal regulator issued a public health advisory warning of possible kidney failure, congestive cardiac failure, cardiovascular toxicity, and strokes as Trasylol side effects.

In January 2007, the Journal of American Medical Association reported that using Trasylol during the heart surgery could increase the risk of death within five years by nearly 50 percent. A report by the Ottawa Health Research Institute published in October 2007 highlighted how Trasylol users were more prone to cardiac arrest and death compared to other drugs in the same class. Bayer declared suspension of Trasylol sales worldwide in the first week of November.

Two research reports published in early 2008 on comparative benefits of aprotinin and aminocaproic acid-based drugs showed that Trasylol could double the risk of revascularization and dialysis need compared to other anti-bleeding drugs. A program aired on CBS “60 Minutes” on February 17th, 2008 disclosed that Bayer did not report to the FDA about the dangerous side effects of the drug found in an additional study conducted in 2006. It cited a Harvard researcher, who was part of the study and had blown the whistle about the hidden information. In the face of protests and pressure, Bayer finally agreed to remove the drug permanently from the U.S. market in May 2008.

Trasylol Litigations

In April 2008, Bayer’s CEO publicly admitted that the manufacturer of Trasylol was facing 78 lawsuits in various U.S. courts. There was a spurt in lawsuits after the CBS program in 2008 claimed that 22,000 lives would have been saved had there been timely action by the FDA and Bayer in January 2006. All lawsuits against Bayer were consolidated in the U.S. District Court for the Southern District of Florida following a court order in March 2009.

Bayer settled another 150 lawsuits in August 2010. The pharma major had paid $60 million to litigants, with an average payout of about $400,000. Until the end of 2010, there were more than 1,600 Trasylol lawsuits filed in various states. According to reports in the Legal Intelligencer, the manufacturer is looking to settle all Trasylol lawsuits and is ready to dole out $400,000 -$510,000 per plaintiff.

Trasylol Side Effects

Cardiovascular problems:

According to a report in the New England Journal of Medicine, Trasylol is responsible for increasing heart attack and stroke risks in users. It also causes atrial fibrillation, hypotension, tachycardia, and myocardial infarct. Trasylol can destroy heart tissues by obstructing the blood supply to the pulmonary muscles. The drug causes prevention of fibrinolytic process which may cause congestive heart failure, heart block, thrombosis, ventricular arrhythmia, and pulmonary hypertension.

Hypersensitivity:

Trasylol users reportedly had skin eruptions, difficulty in respiration, and fatal anaphylactic shock. Many patients also had circulatory failure caused by the drug.

Hematologic disorders:

Aprotinin is responsible severe thromboembolism in users. Research studies have highlighted coagulation disorder, anemia, and thrombopenia disease as possible side effects of in Trasylol.

Renal problems:

Trasylol was one of the drugs most reported to the FDA for causing kidney failure. In 2007, a report in the New England Journal of Medicine estimated that the drug was responsible for 10,000-11,000 cases of kidney failure every year and its ban could save more than $1 billion spent every year on dialysis. Abnormal kidney function and kidney tubular necrosis were also widely reported among the users of the drug.

Hepatic problems:

Abnormal liver functioning noticed in Trasylol users was a possible side effect of the drug. Jaundice and hepatic failure were reported in about 2 percent of the patients.

Other side effects:

Trasylol reportedly caused sepsis, multi-system organ failure, respiratory problems, and immune system disorder in users. Aprotinin is known to cause lung disorder, pleural effusion, and asthma. A few users of the drug also had pneumonia, apnea, and lung edema within years of using it. Nervous system disorders, such as dizziness, anxiety, and convulsion, and musculoskeletal problems, including arthralgia, are among other side effects of Trasylol.

Digoxin Side Effects Lawsuit Attorney

2011-06-21T07:35:48+00:00

Digoxin Side Effects Lawsuit Attorney

Digoxin has been used under the brand name Lanoxin and Digitek for over 250 years. Used primarily for treating individuals with heart problems, abnormal heart rhythms, structural heart diseases, congestive heart failure, Digoxin is known to make the heart more efficient during contraction. The recommended dosage of Digoxin is 10 micrograms per kilogram a day. However, Digoxin has numerous side effects, which have called for a number of lawsuits against the drug manufacturer. Any overdose of the drug can become extremely serious, especially for kids.

Common Side Effects of Digoxin

In several cases, Digoxin causes drowsiness, dizziness or light-headedness, irregular heartbeat, vision changes, vomiting, upset stomach, fever, severe allergic reactions, diarrhea, tightness in the chest, difficulty breathing, unusual tiredness, unusual bruising, confusion, mood or mental changes, unusual weight gain, swelling of the mouth, hands, lips, tongue, or feet, and persistent nausea.

Patients with underlying renal, thyroid disease, cardiopulmonary, and electrolyte imbalances are more vulnerable to Digoxin side effects, which are usually dose-related and occur when serum digoxin levels go beyond 2.0 ng/mL. Patients are more at the risk of cardiovascular problems.

Digoxin Cardiovascular Problems

One of the severest side effect of an overdose of Digoxin is

Vioxx Side Effects Lawsuit Attorney

2011-06-19T01:47:16+00:00

Vioxx Side Effects Lawsuit Attorney

Merck’s arthritis drug Vioxx, known generically as rofecoxib, has the distinction of being the drug most reported to the FDA for its side effects. Though the drug was withdrawn from the market in 2004, Merck continues to face several class action and anti-trust lawsuits in different countries. There were more than 25,000 lawsuits and 160 class actions in the United States alone, of which many cases are yet to be decided. In July 2008, Merck pledged $4.85bn as compensation to be paid against Vioxx legal claims by U.S. residents alone.

Vioxx Complaints and Reports

The FDA approved Vioxx in 1999 to treat arthritis. Soon the drug became one of the most prescribed in the medical history. Doctors prescribed tablets, oral suspensions, and injections of the drug for arthritis and conditions leading to chronic or acute pain. However, studies and research reports in subsequent years linked the drug to increased heart attack risk and other serious health concerns.

Vioxx Side Effects Lawsuit Attorney

A study report known as the Vioxx GI Outcomes Research (VIGOR) published in 2001 disclosed that the drug could cause four-fold increase in acute myocardial infarction risk in users. It established that patients became subject to this elevated risk after using the drug for a month. Nine months after the report was submitted to the FDA, the federal regulator issued warnings to Merck in September 2001. The manufacturer introduced labelling changes warning increased cardiovascular risk on Vioxx in April 2002.

In late 2001, a

Avandia Lawsuit Attorney

2011-06-11T23:38:06+00:00

Avandia Lawsuit Attorney

Avandia Side Effects Lawsuit

Avandia Diabetes Pill: Side Effects and Lawsuits

The FDA has announced a ban on the retail sale of diabetes drug Avandia with effect from November 18th. The decision of the federal regulator made public on May 17th was expected after several complaints of heart problems caused by the drug were surfaced in the recent years. Approved in 1999, Avandia is widely reported to have caused cardiovascular and other health problems in users. Various surveys and research reports have also linked the drug to increased heart attack risk in people with Type 2 diabetes.

Avandia, the generic name of the drug rosiglitazone, is already subject to restricted use in the United States following the FDA label changes in 2010 specifying minimum conditions required for users. The drug has caused more than 100,000 heart attacks in the United States and manufacturers GlaxoSmithKline (GSK) and SmithKline Beecham Corporation are facing several lawsuits for failing to inform users appropriately about its side effects.

Avandia Lawsuits

South Carolina State Sues Avandia Maker

Just a day before FDA decision on retail marketing ban, the

Seroquel Side Effects Lawsuit Attorney

2011-06-08T09:27:52+00:00

Seroquel Side Effects Lawsuit Attorney

The U.S. Agency for Healthcare Research Quality announced on May 24th its plan to conduct a nationwide survey on comparative impact of Seroquel and lithium on patients with bipolar disorder. It has earmarked $10 million to study the detailed impact of the drug on patients being treated at 10 hospitals in the country. This comes on the heels of a startling disclosure made by the Department of Health and Human Services in the first week of May about unauthorized administration of Seroquel and other strong antipsychotic drugs to elderly nursing home residents throughout the country. The report also alleged that such unnecessary administration thrived on the kickbacks paid by drug makers. The disclosure came after a Congressional member questioned about Seroquel second generation antipsychotic mood-stabilizing drug given to hundreds of thousands of elderly dementia patients staying in nursing homes.

AstraZeneca’s Seroquel, which contains Quetiapine, is an atypical antipsychotic drug used to treat schizophrenia, acute bipolar disorder, and severe depression. However, this second generation mood-stabilizing medication causes toxicity, serious neurological disorders, glucose intolerability, early onset of diabetes, and metabolic side effects in patients.

Seroquel Complaints

The FDA approved Seroquel in 1994 for treatment of schizophrenia. It was allowed as a medication for mania-associated bipolar disorder in 2004. However,

Botox Side Effects Lawsuit Attorney

2011-06-08T09:19:43+00:00

Botox Side Effects Lawsuit Attorney

The New Jersey Assembly Health and Senior Services Committee approved a bill on May 19th proposing a ban on injecting Botox to people younger than 18. The bill prohibits minors from taking botulinum toxin injections for cosmetic purposes unless a doctor prescribes them for medical problems. It cites a report by the American Society for Aesthetic Plastic Surgery that warns of large-scale use of these injections by teenagers and concomitant side effects. It followed the widely published news of a California mother giving Botox injections to her 8-year-old daughter to prepare her for a beauty pageant contest. The San Francisco Human Services Agency began an investigation and the mother was relieved of the responsibility of the custody of the child after the incident sparked protests from the medical community and child right activists.

Botox is used to treat strabismus, facial spasms, and neurological disorders by preventing abnormal muscle contractions. Its cosmetic use has been very popular as the botulinum toxin protein smoothes facial wrinkles. However, if not carefully targeted, the drug can lead to serious side effects, including death.

Botox Side Effects Complaints

The FDA allowed Allergan to manufacture and distribute Botox in 1989 for therapeutic use in patients above 12 years. It approved its cosmetic use in April 2002. However, the drug was linked to deaths and several other harmful side effects soon. A report in the Journal of American Academy of Dermatology’s September 2005 issue revealed that about 28 individuals had died due to Botox between 1989 and 2003. This led to demand for investigations, which revealed that Botox could spread to other areas in the body and impact them. The FDA admitted in February 2008 that the drug was responsible for serious adverse reactions, such as respiratory failure and death.

In April 2009, the FDA announced updated

Lipitor Lawsuit Lipitor Side Effects

2011-06-08T08:36:25+00:00

Lipitor Lawsuit Lipitor Side Effects

Setting a historic milestone in the U.S. pharmaceutical industry, a Washington federal judge has granted Ranbaxy exclusive rights to market generic Lipitor for six months. On May 2, the court dismissed Mylan's suit challenging the FDA decision to allow Ranbaxy exclusive rights to sell generic version of the drug. Ranbaxy has plans to introduce the drug with generic atorvastatin calcium in the United States on November 30. The new version will give users an option to buy Lipitor at a cheaper rate.

Sold by Pfizer, lipid-lowering medicine Lipitor is the top-selling prescription drug in the world. Lipitor lowers blood cholesterol, stabilizes plaque, and forbids strokes through anti-inflammatory mechanisms. It inhibits HMG-CoA reductase enzyme that helps in the production of cholesterol in humans. However, the drug can cause several side effects, including devastating effects on human muscle and nerve cells. Memory loss, fatigue, myopathy, insomnia, chest pain, urinary tract infection, myalgia, and severe allergic reaction are among the serious side effects of Lipitor.

A feature story entitled "Life After Lipitor" published by Californian newspaper Tahoe World on January 27, 2004 highlighted the plight of a Lipitor user from Tahoe City. Doug Peterson, the victim, developed severe neuromuscular problems within two years of taking Lipitor. He experienced lack of muscular coordination, loss of effective motor skills, balancing problems, and trouble talking. His health began improving after he stopped taking the drug. It followed by several reports in medical journals and websites highlighting numerous adverse side effects of the drug. Since then it has been linked to multiple sclerosis, memory loss, motor neuropathy, vertigo, disorientation, and stiffness in neck and calf muscles as corroborated by the users of the drug.

Lipitor Side Efects Class Action Lawsuit Attorney

A class action lawsuit was filed against Pfizer in June 2006 in New York State Supreme Court alleging failure to inform doctors and patients about serious side effects linked to Lipitor. It claimed that the drug caused memory loss and debilitating muscle and nerve problems to several users in New York and Atlanta. One of the plaintiffs, 60-year-old Atlanta man Charles M. Wilson, had complained that he continued suffering balancing problems, memory loss, and fatigue even three years after giving up Lipitor. Another lawsuit by 47-year-old New Yorker Michael Mazzariello alleged that he incurred debilitating damage to muscle cells and loss of memory after using cholesterol-lowering drugs, such as Lipitor. The complainants were of the view that Pfizer promoted the drug as safe and with minimal risks in its ads while doctors and patients came to know about its more dangerous side effects after using it.

Lipitor Side Effects Dangerous Lipitor

Atorvastatin, the main component in Lipitor, causes

Vicodin Side Effects Lawsuit Attorney

2011-06-08T08:58:48+00:00

Vicodin Lawsuit Vicodin Side Effects Lawsuit Attorney

In January 2011, the government announced its intention to limit use of some of the most popular prescription painkillers, including Vicodin. It cited reports of poisoning caused by many patients due to acetaminophen presence in these drugs. The FDA has granted three years to manufacturers of these narcotics drugs with acetaminophen to reformulate them. It has set a new limit of 325 milligrams of acetaminophen in Vicodin-like drugs, less than half of the amount presently allowed. Apart from these, manufacturers and distributors are required to have more explicit warning labels on these drugs.

Vicodin, which contains hydrocodone and paracetamol or acetaminophen mixture, is used to treat moderate to severe pain and cough. Doctors usually prescribe the drug for acute, chronic, or post-operative pains. Vicodin is effective in increasing the patient’s ability to deal with pain and speeds up the recovery process. However, it is listed under the U.S. Controlled Substances Act of 1970 for having hydrocodone, a semi-synthetic opioid analgesic. It has many side effects, including addiction blues.

Due to its widespread side effects, the U.S. laws control production, sale, and usage of Vicodin. Though doctors prescribe only controlled dosage to patients, users often experience dizziness, lightheadedness, vomiting, and sedation. The strength of the drug often induces many patients to become addicted to it. When abused, the drug is likely to influence physical and mental conditions of addicts.

Reports on Vicodin Side Effects

The FDA has named Vicodin a Schedule III drug with the warning that its misuse has the potential to cause

Nuvigil Side Effects Lawsuit Attorney

2011-06-03T09:22:52+00:00

Nuvigil Side Effects Lawsuit Attorney

The latest Drug Safety newsletter of the Irish Medicines Board released on May 15th has warned people against taking recourse to wakefulness promoting drugs, such as Nuvigil and Provigil, to treat excessive sleepiness. It has advised doctors to check heart conditions of patients using electrocardiogram and monitor blood pressure and heart beat regularly before prescribing these drugs. The IMB has also urged caution on the part of users having a history of psychosis, depression or mania.

Though the pharmaceuticals major Cephalon claims that its drug Nuvigil is an effective means to improving conditions of people having sleep apnea, narcolepsy, and shift work sleep disorder, the Side Effects Lawsuit Attorney of the drug can lead to serious health problems. Wakefulness drugs may lead to one sleep problem while solving the other. It can cause lack of sleep that leads to a number of health complications, such as insomnia, fatigue, abnormal blood pressure, and lack of appetite. We need good sleep to help us recuperate and rejuvenate after long working hours. While lack of sleep induced by the drug can impact our efficiency and create mental problems, stimulant-like armodafinil in the drug is linked to Steven’s Johnson syndrome.

FDA Warning on Nuvigil

The FDA approved the marketing of Nuvigil in 2007 only after its manufacturer Cephalon agreed to carry label warnings on it. The federal regulator made a written request to the manufacturer two months before the market introduction of the drug to have mandatory and bold label warnings about skin rash and hypersensitivity Side Effects Lawsuit Attorney. It even asked the company to submit standard safety updates highlighted during clinical trials and mention them in introductory promotional materials. Such requirements are put forward only if the FDA is more concerned about the Side Effects Lawsuit Attorney of a drug. In October 2007, the FDA updated healthcare professionals about warnings related to prescription of Provigil, a lesser variant of Nuvigil.

In December 2010, the FDA rejected Cephalon’s request to allow Nuvigil pill to treat jet lag. Though there was no official word on the reason for not allowing the drug to treat jet lag, speculations were rife that the FDA had greater concerns on Side Effects Lawsuit Attorney of the drug. Similar circumstances had forced the pharmaceuticals major to abandon plans to market Nuvigil for schizophrenia treatment last June.

Propecia Side Effects Lawsuit

2011-05-25T22:36:20+00:00

Propecia Side Effects Lawsuit

Proscar Side Effects Lawsuit

A couple from Polk County, Florida, has filed a lawsuit against Merck & Co. Inc, the manufacturer of Propecia and Proscar, drugs used to prevent male pattern hair loss or baldness. Eddie Sebastia and his wife Lisa claim that the drugs adversely impact their sex life after the husband took Propecia and Proscar from 1998 to 2007. Eddie experienced erectile dysfunction, testicular pain, decreased libido, depression, and anxiety after he was prescribed the drugs to prevent hair loss. The lawsuit accuses Merck of failure to adequately warn users and prescribing physicians about possibility of the drugs resulting in permanent and lasting sexual dysfunction. The user is under medication to get rid of the side effects of the drug.

A similar class action lawsuit has been filed last month by a Connecticut law firm in Federal District Court in New Jersey accusing Merck of not fully informing users and doctors about long-lasting or permanent side effects of Propecia. It seeks damages for users who suffered sexual dysfunction and mental impairment caused by the drug. The lawsuit claims that the pharmaceutical major failed to put a stronger warning label or fully disclose the serious side effects on the drug label. It also accuses Merck of continuing to market the drug ignoring several reports of side effects.

In December 2010, a FDA panel rejected a request by Merck to market Proscar for prostate cancer prevention. The panel debate highlighted the high risk of tumor posed by the drug. It even expressed concern over unfavorable balance of risks and gains for users above

Tylenol Side Effects Lawsuit Attorney

2011-05-25T07:19:46+00:00

Acetaminophen Tylenol Side Effects Lawsuit Attorney

According to a study done by Seattle-based Fred Hutchinson Cancer Research Center, long-term use of painkiller acetaminophen puts users at risk of developing blood cancers. The survey based on a six-year study of 65,000 people above 50 years found that several of chronic acetaminophen users developed blood cancer after taking the drug over a long period of time. Those who took acetaminophen four times or more in a week for four years became twice prone to developing blood malignancies than those who did not use the Tylenol drug.

Acetaminophen, popularly known as Tylenol, is the most commonly used pain killer and anti-inflammatory over-the-counter and prescription drug. It is a component of more than 100 medicines. An overdose of the drug is linked to several health concerns, including liver failure. In recent years, the FDA has issued warnings to drug manufacturers in the United States to use the lowest possible doses of acetaminophen in their products. The federal regulator is concerned over the incidence of its use for variety of medications.

In 2009, the FDA added nonprescription and prescription requirements to provide information regarding hepatotoxicity caused by acetaminophen . It even held a meeting in June 2009 on addressing the problem of liver injury linked to the use of acetaminophen. It is considering the possibility of removing the drug from popular analgesic combination products or lowering its doses. Recently, the drug

Facebook Class Action Lawsuit

2011-05-24T08:59:23+00:00

Facebook Lawsuit

Facebook Privacy Lawsuit

A U.S. District Court in San Jose, California, has allowed a lawsuit accusing Facebook of privacy violations to proceed. The lawsuit has claimed that the most popular social-networking site in the world gave advertisers unauthorized access to personal information of users when they clicked on ads. Though the court dismissed eight claims due to lack of tangible evidence, it rejected the plea by the social-networking site to dismiss the entire lawsuit and allowed five claims to be refiled. Judge James Ware observed that the allegations by the plaintiffs were enough to establish the fact that they have suffered the injury.

The plaintiffs, two individuals from California, filed the lawsuit against Facebook earlier this year seeking damages for injury caused on eight grounds, violation of the Electronic Communications Privacy Act, Stored Communications Act, fraud, breach of contract, unfair competition, and other claims. According to the plaintiffs, Facebook allowed advertisers to access their profiles and personal information after they clicked on advertisements between February 2010 and March 2010. They claim this act of the social-networking major make them feel “injured,” as advertisers are not authorized to access names, genders, and pictures of users without their consent.

Similar Privacy Lawsuits Against Facebook

Facebook is the largest social-networking site with more than 500 million members. However, there have been several complaints against the site for failure to protect the privacy of users. Facebook is also listed by the European Union for possible privacy-rule breaches and unauthorized use of personal data. In 2005, two MIT students demonstrated the possibility of data mining on the Facebook by downloading over 70,000 profile information.

Facebook Data Mining Case in Canada

In May 2009, the Privacy Commission of Canada suggested Internet providers to block Facebook, as it did not comply with national privacy laws. It preceded the famous "minefield of privacy invasion" suit filed by three Ottawa University law students. Facebook agreed to comply with privacy norms suggested under the Canadian Personal Information Protection and Electronic Documents Act after persistent legal pressure.

California Class Action Lawsuits Against Facebook

Chase Class Action Lawsuit

2011-05-19T07:42:55+00:00

Chase Class Action Lawsuit

In what we consider to be a great development for consumer justice, Judge Maxine Chesney has certified the the attorney filed class action lawsuit against Chase Bank the class action lawsuit stems from interest rate increases on Chase Bank check loans.

Lawyers filed the Chase class action lawsuit f in 2009 as a result of Chase promising its consumers lifetime / permanent low interest rates on Chase Bank check loans. The victims in this case were issued Chase credit cards with a minimum monthly payment of 2% on each account. These cards included a credit card check option that allowed the these customers the option to take a loan with a fixed APR ( annual percentage rate ) until the balance was paid off.

However, Chase later failed to hold up their end of the bargain when they forced their customers to make increased minimum payments or pay higher interest rates on the loans.

Hip Replacement Implant Lawsuit Attorney

2011-05-17T07:57:13+00:00

Hip Replacement Implant Lawsuit Attorney

Hip Replacement Implant Class Action Lawsuit

Articular surface replacement DEPUY ASR hip replacement implants were made and marketed by DePuy Orthopaedics.

The hip replacement recall scandals are a result of defective hip replacement implants having a high failure rate as well as causing metal poisoning in some paitents with certain metal on metal hip implants.

The recalled defective hip have resulted in hundreds of patients being poisoned from metal particles found in the defective hip replacements.

Some news media are calling the failed hip implant lawsuits the worst disa

ster in the history of orthopaedic sugery.

The articular surface replacement (ASR) hip was made and marketed by

DePuy Orthopaedics, a subsidiary of the Johnson & Johnson company. As a result , patients have already filed hip replacement lawsuits against the company seeking a variety of damages.

Although Depuy recalled the faulty metal on metal Depuy ASR hip by issuing a worldwide recall in 2010, 93,000 patients worldwide had already been implanted with the defective hip replacement device. Hip replacement implant class

action lawsuit proceedings in the United States by members of the doihavealawsuit

.com legal community may have been filed by our affiliated attorneys. Be sure to submit your case or call the lead firm directly for more information.

Patients who received the defective hip replacement implants are likely to undergo the painful process of revision surgery. Hip replacement revision surgery is both complex and painful. These revision surgeries may or may not correct the issues surrounding the failed hip devices. Many recipients of the Depuy ASR hip implant devices also suffered illness from metal poisoning associa

ted with the metal on metal Hip implants.

Hip replacement class action lawsuit damages seek to compensat

e the

se unsuspecting victims of these failed hip implant devices by forcing Johnson and Johnson Depuy Orthopaedics to compensate patients for there pain , suffering and other issues related to their receiving the defective hip implants.

Metal poisioning consisting of both Cobalt and Chromium have been found in the blood and tissue of hip replacement implant patients. These toxic metals can not only cause severe organ damage, but can actually cause tissue death and the premature wearing away of human bones. Cobalt poisoning has also been known to cause tinnitus as well as have serious impact to patient vision.

To contact the lead attorney handling all defective hip implant cases directly, you may submit your case here at Do I Have A Lawsuit or call the lead firm directly to speak to the lead attorney today!

Byetta Lawsuit

2011-05-16T20:00:47+00:00

Byetta Lawsuit

Byetta Side Effects Class Action Lawsuit

Eli Lilly has today released the following statement as it relates to Byetta lawsuits and Byetta side effects. We have decided to share this statement in whole. We do not agree with the statements made by Lilly and feel that Lilly and or any other fat corporation should be held accountable for their actions and feel confident that they will in fact pay the price for their shenanigans jepoardizing the health of consumers.

Their Statement Is As Follows:

INDIANAPOLIS, May 16, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided the following statement in response to a lawsuit and motion for temporary restraining order filed by Amylin Pharmaceuticals, Inc. against Lilly. The action was filed in the United States District Court for the Southern District of California.

"We believe the lawsuit is without merit and will vigorously defend our position," said Enrique Conterno, president of Lilly Diabetes. "Lilly has been and remains fully committed to fulfilling its obligations under its exenatide collaboration agreement with Amylin, as well as to complying with all laws and regulations. We look forward to building on the alliance's success achieved to date."

"Our mission as a company is to bring needed therapeutic solutions to patients," added Conterno. "Significant unmet need exists among patients with diabetes, and the condition's prevalence and complications from it are projected to rise sharply as we look to the future. Lilly has a strong heritage of bringing new diabetes innovations to the market and we know that patients and health care professionals want choices to treat this complex disease throughout its progression."

Since the alliance's inception, Lilly has devoted significant talent, resources, and know-how to the collaboration's efforts and has been instrumental in the success of the marketed medicine BYETTA® (exenatide injection) and in the development of BYDUREON™ (exenatide extended-release for injectable suspension), which received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) in April. The alliance plans to submit a response to the U.S. Food and Drug Administration's complete response letter in the second half of 2011.

About BYETTA® (exenatide) injection

BYETTA was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

Lynchburg Wrongful Death Lawsuit

2011-05-16T08:53:40+00:00

Lynchburg Wrongful Death Lawsuit

In a three-day-long jury trial, the plaintiffs in the Lynchburg wrongful death lawsuit have settled for $250,000, in place of their earlier $12.5 million claim in the Lynchburg Circuit Court. The plaintiffs settled the case after the state agreed to pay $250,000 as compensation, apologized for the tragedy that claimed the life of plaintiffs’ brother Clarence Beard Jr., and agreeing to clear the name of the deceased that he was not a drug addict, nor was he drunk that fateful day.

About the Wrongful Death Lawsuit

The wrongful death suit, filed against seven Lynchburg police officers, claimed gross negligence on the part of the defendants that caused the death of Clarence Beard Jr. in 2006. The plaintiff, Mary Peterson, who is Beard’s sister, sought $12.5 million compensation in the lawsuit filed in 2008 for negligence, assault and battery, false arrest and imprisonment. The lawsuit alleged that, on September 24, 2006, the defendant police officers, Michael B. Eagle and Michael A. Huntsman, entered the deceased’s apartment, looking for a woman without search warrants. The suit asserted that, initially, the deceased allowed them to search his room, but later, when he exercised his right to ask the officers to produce the warrant, he was ruthlessly rounded up, hog-tied, and falsely arrested, which contributed to his heart attack and death. The suit also named backup officers, Jerry R. Mayberry, Chad T. Davis, Timothy C. Clements, C. Scott Bradner, and Thomas B. Lawton.

Chantix Lawsuit Chantix Side Effects

2011-05-16T04:30:16+00:00

Chantix Lawsuit

Chantix Side Effects

A lawsuit filed on May 9th in a Pennsylvania court claims that antismoking drug Chantix causes psychotic rage in users. According to the product liability lawsuit, a 34-year-old man experienced rage and inhibited violent behavior two weeks after he was prescribed the drug to help him quit smoking. It is alleged that, under the imapct of the drug, the man shot his wife and committed suicide.

The FDA allowed Pfizer to market Chantix in 2006. Musician Carter Albrecht was the first high-profile victim of the drug. When he was shot dead in September 2007 by his girlfriend's neighbor, his relatives, including his girlfriend, claimed that erratic behavior induced by the drug led to his death. More such cases prompted FDA warning a month later linking Chantix with possible serious neuropsychiatric symptoms, such as suicide ideation, erratic behavior, and sudden violent disposition.

In May 2008, the U.S. Federal Aviation Administration banned pilots and air traffic controllers from taking varenicline, the key component in Chantix, fearing its adverse neuropsychiatric effects can cause serious public safety issues. It followed warnings by manufacturer Pfizer that the drug exposes users to the risks of traffic violations and accidents. In July 2009, the FDA made Boxed Warning on product labels of Chantix mandatory.

Drug Side Effects Lead To Blood Cancer

2011-05-14T07:40:30+00:00

Drug Side Effects Lead To Blood Cancer

FDA Warns Bowel Drug Side Effects Lead To Blood Cancer

According to the Federal Drug Administration’s drug safety alert issued on April 14, certain drugs used to treat inflammatory bowel disease (IBD) can cause blood cancer in patients. Commonly known as tumor necrosis factor (TNF) blockers, these drugs include Humira, Remicade, Cimzia, Enbrel, Simponi, and others with Azathioprine and Mercaptopurine as solutions. The FDA has received 43 reports linking these bowel drugs with Hepatosplenic T-Cell Lymphoma, a rare cancer that affects white blood cells in children and young people.

The HSTCL cancer is highly aggressive and spreads quickly. In most of the reports that the FDA has received, patients developed the cancer after using TNF blockers to treat ulcerative colitis and Crohn’s disease, the two common forms of IBD. Two patients diagnosed with HSTCL are found to have taken these drugs while undergoing treatment for rheumatoid arthritis. One patient developed cancer after he was prescribed these drugs for psoriasis treatment.

Remicade is found to be

Yasmin Lawsuit Yaz Lawsuit Side Effects

2011-05-11T08:41:18+00:00

Yasmin Side Effects Birth Control Pills Lawsuit

Yasmin Lawsuit Yaz Lawsuit Side Effects

Two new scientific studies conducted separately in the United States and United Kingdom have revealed that the new generation birth control pills, produced in the 1980s, containing hormone drospirenone, increase the risk of blood clot in women. According to the study published in Boston University School of Medicine report, drospirenone triples the risk of blood clots compared with levonorgestrel, which is found in older version of contraceptives. The US study conducted by Jick from the Boston University School of Medicine was based on research as well as information from a United Kingdom research database.

The study claims that pills containing synthetic hormone levonorgestrel are safer than the drospirenone ones, such as Yasmin and Yaz, as far as risk of blood clots is concerned. The research concludes that of 100,000 women using drospirenone pills, 30.8 develop blood clots, compared to 12.5 in the case of levonorgestrel pills.

The research, led in the United States by Jick from the Boston University School of Medicine, used information from US medical claims data and UK research database, to identify the risk for women using drospirenone pills. This is not the first time concerns have been raised over drospirenone pills. Recently, a woman filed a lawsuit against Bayer, alleging that she suffered a stroke from Yasmin side effects. Many other women have also filed lawsuits against Bayer, alleging that they suffered from injuries as a result of blood clots after consuming Yasmin. Statistics reveal that over 7,000 lawsuits are pending in the United States and 400 in Canada against Bayer over alleged injuries and deaths related to the use of Yasmin, Yaz, and other drospirenone contraceptives.

The report says that hormone progestogen and drospirenone can cause pulmonary embolism and thromboembolism, which is the formation of blood clots in leg and arm veins. These clots, drifting through the blood circulatory system, are entrapped in brain, lungs, and heart, causing infarctions due to blockage.

The reports support recent findings about drospirenone oral contraceptives, which claim that levonorgestrel oral contraceptives are safer than drospirenone pills as far as venous thromboembolism is concerned. The report further states that women considering taking these pills should be aware of the risk associated with their use.

Yasmin Lawsuit US Study

The US study was conducted on women

Accutane Side Effects Lawsuit Attorney

2011-05-10T21:19:45+00:00

Accutane Side Effects Lawsuit Attorney

Hoffman-La Roche’s Accutane is used to treat nodular acne. It is usually advised after other acne medicines or antibiotics fail to show any effect. However, the drug has severe temporary and permanent side effects that cause serious health problems. In October 2010, the FDA made an appeal to the people not to buy Accutane on the Internet. It asked users of the drug to look for prescriber and pharmacist certification and properly read the safe use documentations before buying the same. A number of common and rare side effects of the drug were also mentioned in the warning. The FDA has been receiving several reports linking Accutane to suicide attempts and harmful effects on fetus since 2007.

Health Problems Posed by Accutane Side Effects

Common Accutane side effects observed in users include higher Vitamin A toxicity, severe acne flare, skin and lip dryness and cracking, allergies, cuticles infection, dryness and irritation in eyes, reduced tolerance to contact lenses, increased liver enzymes, permanent thin skin and hair, and back pain. A study conducted in Mexico found patients using the drug suffering from raised blood glucose level and erectile dysfunction. Accutane in rare cases is found to have caused impaired night vision, cataracts, inflammatory bowel disease, weight loss, edema, and skeletal hyperostosis. Hair loss, degenerative disc disease, and bone disease are some of the permanent side effects of the drug.

Cardiovascular Side Effects Lawsuit

There are reports of young men suffering from symptomatic heart palpitations within three to four weeks of taking Accutane. The drug also causes vascular thrombotic disease, inflammation of blood vessel, heart stroke, and

Oxycodone Side Effects Lawsuit Attorney

2011-05-04T02:52:44+00:00

Oxycodone Side Effects Lawsuit Attorney

Popularly known as OxyContin or Oxy, Oxycodone is a highly addictive prescription drug, primarily used as a painkiller. Due to its highly addictive properties, Oxycodone has become one of the most abused drugs in the United States. According to statistics, prescription painkillers and opioids kill more people than cocaine and heroin combined and cost $484 billion annually. The Drug Enforcement Administration (DEA) statistics put the number of illicit users of Oxycodone at 1.9 million in the country. To check the growing menace of Oxycodone abuse and drug addiction, the federal government has formulated the first nationwide strategy, which aims to cut prescription drug misuse by 15 percent over a period of five years.

What is Oxycodone

Developed in 1916, Oxycodone was approved by the FDA in 1976. Oxycodone is an opioid analgesic drug prescribed for moderate to severe pain. Often patients suffering from frequent pain are prescribed a daily dose of Oxycodone, which results in physical dependence for most of the individuals. However, it does not eliminate the pain sensation but only increases tolerance to pain by causing sedation.

Oxycodone Abuse

The easy accessibility of Oxycodone has made it one of the most abused drugs in the United States. When abused, Oxycodone has a high potential of addiction. It lessens anxiety and causes a euphoric feeling. It is highly popular with adults and teens alike. In fact, among teenagers, the abuse of Oxycodone is on the rise. According to reports, one in every 20 high school students takes OxyContin and a number of teenagers have died as a result of OxyContin abuse. Oxycodone Side Effects Lawsuits have been filed by various attorneys for because of this.

Oxycodone is one of the most abused schedule II drug in the country. It is an extremely dangerous drug due to its addictive properties. Patients taking Oxycodone on a regular basis tend to develop physical dependency on it. Physical cravings for the drug increase as the body becomes dependent on it. Oxycodone causes severe withdrawal symptoms if the use is discontinued. In case of Oxycodone addiction, dependence turns into compulsion and obsession, and the individual becomes excessively dependent on the drug to the extent to derive euphoria and “high” from it. Some lawyers in previous oxy side effects lawsuits have used this fact in court.

Lawsuit Category Browser

Hysterectomy Side Effects

Hysterectomy Side Effects

Hysterectomy Statistics

Prescription Drugs Addiction During Pregnancy And Opiate Abuse

Prescription Drugs Addiction During Pregnancy And Opiate Abuse

Opiate Painkiller Abuse Number of Newborns With Withdrawal Syndrome Triples

Victoza Side Effects Lawsuit Information

Victoza Side Effects Lawsuit Information

Breast Cancer Treatment Side Effects Lawsuit

Breast Cancer Treatment Side Effects Lawsuit

Breast Cancer Treatment Side Effects

Research Studies on Side Effects of Breast Cancer Treatments

Victoza Side Effects Lawsuit

Victoza Side Effects Lawsuit

Cruise Ship Lawsuit

Cruise Ship Lawsuit

Cruise Ship Liability and Admiralty Lawsuit

Surgical Error Malpractice Lawsuit

Surgical Error Malpractice Lawsuit

Surgical Error Lawsuit

Surgical Error: Meaning and Types

Grounds for Filing Surgical Error Lawsuit

Zocor Side Effects Lawsuit

Zocor Side Effects Lawsuit

Pradaxa Side Effects Bleeding Lawsuit

Pradaxa Bleeding Lawsuit

Pradaxa Internal Bleeding

Zoloft Side Effects Lawsuit Birth Defects

Zoloft Birth Defects Lawsuit

Cooper Vision Avaira Toric Contact Lens Lawsuit

Cooper Vision Avaira Toric Contact Lens Lawsuit

Cooper Vision Recalls Avaria Contact Lenses

Medtronic Infuse Bone Graft Lawsuit

Medtronic Infuse Bone Graft Lawsuit

Merck Lawsuit Settlement

Merck Lawsuit Settlement

Wrongful Birth Lawsuit

Wright Medical Hip Lawsuit Implant Replacement

Wright Medical Hip Lawsuit Implant Replacement

Cigarette Tobacco Lawsuit

Cigarette Tobacco Lawsuit

Transvaginal Mesh Lawsuit

Transvaginal Mesh Lawsuit

Mesh Lawsuit Attorney

Vaginal Mesh Implant Attorney Studies

Medical Malpractice Lawsuit

Actos Bladder Cancer Lawyer

Actos Bladder Cancer Lawyer

Actos Bladder Cancer Side Effects

Actos Bladder Cancer Side Effects Complaints

Do i Have A Lawsuit Attorneys Investigate

Actos Bladder Cancer Research Studies

US FDA Report on Actos Bladder Cancer Risk

European MedicalAgency Study on Actos Bladder Cancer Risk

Medical Malpractice Lawsuit

Medical Malpractice Lawsuit

Medical Malpractice Lawsuit

Discrimination Lawsuit

Discrimination Lawsuit

Multaq Side Effects Lawsuit

Multaq Side Effects Lawsuit

FDA Issues Black Box Warning for Multaq

School Sexual Abuse Lawsuit

Sexual Abuse Lawsuit

Actos Bladder Cancer Side Effects Lawsuit

Actos Bladder Cancer Side Effects Lawsuit

Actos Bladder Cancer Lawsuit

Actos Bladder Cancer

Sexual Abuse Lawsuit

Sexual Abuse Lawsuit

Penn State Sandusky Child Molestation Abuse

Penn State Sandusky Child Molestation Abuse

Nursing Home Abuse Neglect Lawsuit

Nursing Home Abuse Lawsuit

Nursing Home Neglect and Abuse Lawsuit

Nursing Home Neglect and Abuse Grounds for Lawsuit

Head And Spinal Injuries Lawsuit

Head And Spinal Injuries Lawsuit

Grounds for Filing Brain and Spinal Injuries Lawsuit